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ABSTRACT
Malaria significantly contributes to morbidity and mortality rates in Zambia. The
currently accepted malaria treatment is artemisinin-based combination therapy (ACT); it is more
than 97% effective when the regimen is strictly adhered to. However, the mean ACT adherence
rate in sub-Saharan Africa is only approximately 38-48%. Poor pharmacoadherence remains a
significant barrier to malaria control and elimination.
The purpose of this study was to determine if adherence rates to a six-dose ACT
antimalarial treatment differ between patients in Zambia who received short message service
(SMS) reminders and those who did not.
An experimental, randomized, controlled trial was conducted to collect data from a
sample of 96 adult patients with malaria who presented to Fisenge Clinic in the Copperbelt
Province of Zambia. Participants were randomly assigned to a control or intervention group.
The intervention group received SMS messages to remind them to take their medication
according to the regimen. An electronic pillbox was used to measure pharmacoadherence for
both groups, and patients were classified as probably adherent or probably non-adherent.
Data were analyzed using Chi-square for association between the SMS intervention and
pharmacoadherence, and logistic regression used for predictors of adherence. No significant
association was found between SMS reminders and pharmacoadherence among malaria patients
being treated with ACT when evaluated with respect to those who received the SMS reminders
and those who did not (χ2=0.19, df=1, p=0.67). Binary logistic regression indicated that there
were no variables associated with adherence (p>0.05).
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Findings from this study contribute to the research regarding the use of mobile phones to
promote adherence. This is the first study of its kind using SMS directly to the patient for ACT
adherence in sub-Saharan Africa known to the author. It is possible that the use of the electronic
pillbox and/or the novelty of participating in a research study contributed to higher levels of
adherence than previously found in this geographical area. While data suggested that there was
no association between SMS and adherence, further research is needed to explore the value of
this intervention.
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CHAPTER ONE: THE PROBLEM
Introduction
The estimated global toll of malaria in 2012 was 207 million cases associated with
627,000 deaths (World Health Organization [WHO], 2013). Eighty-six percent of presumed and
confirmed malaria cases in the world occurred in Africa with the majority of these in subSaharan Africa. Zambia, located in the heart of sub-Saharan Africa, is plagued by malaria,
particularly the Plasmodium falciparum (P. falciparum) species. The annual number of
diagnosed and confirmed cases in Zambia, in 2012, was 4.7 million, 2.3% of the total global
cases, with an estimated 11,000 deaths (WHO, 2013). Of individuals diagnosed with P.
falciparum malaria, 90.5% will die if left untreated (Roll Back Malaria [RBM], 2008). In
addition to the significant impact on morbidity and mortality, this parasitic infection is estimated
to cost African countries a total of more than $12 billion annually through diagnosis, treatment,
and lost productivity, equaling 2-3% of the adjusted Gross National Product of the continent
(Gallup & Sachs, 2000; RBM, 2003).

Background
Detection
Accurate malaria detection is critical for combatting the disease. While microscopy is the
gold standard for diagnosis of malaria, the cost and lack of availability of trained laboratory
technicians prevent widespread use in resource-limited settings (Murray, Gasser, Magill, &
Murray, 2008). Currently, Zambian clinics utilize the rapid diagnostic test (RDT) as the
accepted diagnostic test.
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Treatment
The current pharmacological treatment for uncomplicated P. falciparum malaria,
recommended by the WHO, is an artemisinin-based combination therapy. Artemesinin-based
combination therapy (ACT) utilizes two schizontocidal medications given concurrently with
independent modes of action to improve therapeutic efficacy and to interrupt the development of
resistance to the separate components of the blend (WHO, 2006a). ACT also helps prevent the
emergence of parasite drug resistance through the interference of asexual replication (White et
al., 2009; WHO, 2013). The ACT medication regimen, which has not been modified since 2006,
consists of six doses to be taken twice daily over three days, with the 2nd dose 8 hours after the
initial dose which is administered at the clinic and subsequent days’ doses 12 hours apart
(President’s Malaria Initiative, 2011; WHO, 2006a). The extent to which one follows the
prescribed regimen is referred to as adherence or pharmacoadherence. This regimen is critical
and has been found to be more than 97% effective when strictly adhered to, resolving clinical
symptoms even before the regimen is complete (Abdulla et al., 2008; Makanga et al., 2011).
Artemether-Lumefantrine is the accepted first-line ACT being prescribed in Zambia (WHO,
2013). Research shows that giving the second dose of artemether-lumefantrine (AL) 8 hours
subsequent to the first ensures that the concentration of artemether is sustained above the
minimum effective concentration level. This level is necessary in order to maintain the high
level of exposure of malaria parasites to the medication during the portion of their life cycle in
which they are most susceptible to anti-malarial agents (Kokwaro, Mwai, & Nzila, 2007; White,
1992).
Though researchers have been able to successfully decrease the duration of treatment
from the 14-day chloroquine treatment to the current 3-day ACT treatment, pharmacoadherence
2

remains a stumbling block in the fight against malaria (RBM, 2010; WHO, 2006a; Yeung &
White (2005).

Pharmacoadherence
Current statistics for malaria treatment pharmacoadherence rates in sub-Saharan Africa
vary widely in their methods and definitions resulting in a range between 36.5% and 91% (M =
61.2; SD = 20.0). Over 50% of studies use self-report as the primary measurement tool and few
take the timing of the medication into consideration (Ansah, Gyapong, Agyepong, & Evans,
2001; Cohen, Yavuz, Morris, Arkedis, & Sabot, 2012; Depoortere et al., 2004; Fogg et al., 2004,
Lawford et al., 2011; Lemma, Löfgren, & San Sebastian, 2011; Okonkwo, Akpala, Okafor,
Mbah, & Nwaiwu, 2001; Onyango et al., 2012; Yeboah-Antwi et al., 2001).
Non-adherence not only impacts the patient through suboptimal blood concentrations
resulting in increased morbidity and mortality, but also impacts the community, through the
development of parasitic resistance, disease relapse, and increased disease occurrence (Mace et
al., 2011; White & Olliaro 1996; White et al., 2009). This problem requires the development of
a multifaceted approach and enhancement of current strategies to improve pharmacoadherence;
however, the causes for failure to adhere must first be determined in order to shape effective
strategies.
Pharmacoadherence has been associated in part with socio-economic, environmental, and
demographic differences (e.g. age, education level, ability to read, and household income), as
well as personal characteristics such as forgetfulness, carelessness, symptom reduction, and the
side effects associated with the treatment (Morisky, Green, & Levine, 1986; Onyango et al.,
2012; WHO, 2003). While there has been significant research conducted in order to explore the
3

factors related to pharmacoadherence, this study focuses on variables associated with adherence
in sub-Saharan Africa.
Specific attempts to improve pharmacoadherence have included observation, the blister
pack, and electronic pillboxes such as the Medication Event Monitoring System (MEMS)
(Kahook, 2007) and SIMpill (2008). Observation encourages adherence through accountability
and offers the surest confirmation of pharmacoadherence, but the practicality of observation with
medication sequences such as the ACT regimen is prohibitive. Virtual direct observation
treatment (DOT) is one method using technology for observation that is currently being
researched (Hoffman et al., 2009).
When observation proves impractical, blister packs improve pharmacoadherence by
addressing the forgetfulness aspect through visual cues that indicate whether a patient has taken
his or her dose. These pill containers include individually packaged pills in a “blister” or
“bubble” that is pierced to obtain the pill. The vacant blister or bubble indicates that the pill has
been removed, and in pharmacoadherence studies, if the pill is removed the patient is assumed to
have taken it. The patient and caregiver can use the blister pack container to verify pill counts or
to stay on regimen. While at least two studies using blister packs have resulted in greater than
95% adherence using blood tests to confirm presence of the drugs, the timing aspect as a critical
component of ACT treatment is not addressed with this method (Qingjun et al., 1998; Shwe,
Lwin, & Aung, 1998). Despite the current use of blister packs, poor pharmacoadherence due to
forgetfulness, carelessness, symptom reduction or negative side effects continues to thwart
malaria eradication.
One electronic pillbox, the MEMS cap, monitors and records the number of bottle
openings and the date and time of each opening, which can then be downloaded to a computer
4

for analysis. One prospective descriptive laboratory study verified the reliability of the model of
MEMS used in this study resulting in 100% perfect functioning with a total absence of missing
registrations and/or over-registrations (DeBleser, DeGeest, Vandenbroeck, Vanhaecke, &
Dobbels, 2010).
The MEMS has been found to motivate pharmacoadherence through accountability, and
has been determined to be suitable and achievable in a resource-limited setting such as subSaharan Africa (Fallab-Stubi, Zellweger, Sauty, Uldry, Iorillo, & Burnier, 1998; Kahook, 2007;
Lyimo et al., 2011). Some of this research, though conducted with anti-retroviral therapy (ART),
resulted in a 97% (n=23, SD = 4.7) adherence rate in the first month of use, the time period
relevant to short-term regimens such as ACT (Lyimo et al., 2011). While MEMS is considered
to be the imperfect gold standard and more valid than self-report, research indicates that
pharmacoadherence studies should not rely on MEMS alone, but use multiple adherence
measures (Cook, Schmiege, McClean, Aagaard & Kahook, 2012; Claxton, Cramer, & Pierce,
2001).
An alternative electronic pillbox recently on the market is SIMpill, which electronically
monitors pillbox openings and sends the data to a remote server. If the patient does not take
his/her medication on schedule, SIMpill sends an SMS to the patient and/or healthcare provider
as a reminder (SIMpill, 2008). Though little research has been conducted using SIMpill, one
pilot study implemented in South Africa for tuberculosis (TB) medication adherence resulted in
increased adherence levels from 83% to 92% (Madyo, 2010). As a new product, SIMpill data
and research are limited. The device has currently been removed from the market in Africa
halting further research in the current area of focus (Brendan Rens, Director of SIMpill, personal
communication, August 30, 2013).
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The American Psychological Association’s recommendations to improve
pharmacoadherence are summarized in Table 1 (Chisholm-Burns & Spivey, 2008). These
recommendations are broad and provide opportunity for further study to determine implications
to patient outcomes. The intervention addressed in the current research using mobile phones
seeks to address forgetfulness as a barrier to adherence.
Table 1: Summary of American Psychological Association Recommendations to Promote
Adherence to a Medication Regimen
Recommendations
Explain the medication regimen
Tailor the medication regimen to the patient’s lifestyle and daily routine
Establish collaborative relationship with patient, and facilitate patient interaction with
other pharmacy staff
Identify and address individual barriers (emphasis added) to adherence
Refer special-needs patients to appropriate services
Promote self-efficacy
Create and maintain an environment conducive to pharmacoadherence
Mobile Phones
Recent advancements in mobile phone technology and availability hold promise for
health research application in sub-Saharan Africa. Researchers estimate that 65% of all mobile
phone users can be found in the developing world, with mobile subscriptions in Africa growing
twice as fast from 2003-2008 as any other part of the world (Gardner, Acharya, & Yach, 2007;
Hampton, 2012; United Nations Foundation [UNF], 2012). Over two-thirds of the population in
Africa is covered by a mobile network, which has resulted in individuals who previously had no
access to landlines now having access to low-cost handheld devices with SMS capabilities
(Zurovac, Talisuna, & Snow, 2012). Eighty-seven percent of urban Zambian households and
52% of rural households had access to at least one mobile phone in 2008, with expectations for a
continued rapid rise as the wave of technology floods the continent (Chirwa, 2010). The three
6

primary mobile phone providers in Zambia are MTN, Zamtel and Airtel with all mobile phones
in Zambia having SMS capability and the majority operating on pre-paid plans. All incoming
phone calls and incoming SMS messages are free to the receiver, which presents an economic
advantage to the end-user in impoverished areas.

Statement of the Problem
Although effective treatment for P. falciparum malaria is available, the problem of poor
pharmacoadherence remains a significant barrier to malaria control and elimination (Mace et al.,
2011; White & Olliaro, 1996; White et al., 2009).

Purpose of the Study
The primary aim of this study was to assess the efficacy of a program to increase the
pharmacoadherence rate of the six-dose ACT treatment of P. falciparum malaria in the
Copperbelt Province of Zambia using SMS reminders through the mobile phone. The secondary
aim was to gather information through a brief end-of-study questionnaire regarding factors
affecting pharmacoadherence for further research.

Question
For purposes of this study the original hypothesis was converted to a research question at
the request of the Tropical Diseases Research Centre. Are SMS reminders sent to patients
associated with adherence rates to a six-dose ACT antimalarial treatment in the Copperbelt
Province, Zambia?

7

Original Hypothesis
The use of SMS reminders through mobile phones will increase the adherence rate to a 6dose ACT antimalarial treatment in Luanshya District, Zambia.

Assumptions
The primary assumptions made in this research are that people desire to be well, that they
intend to take medication according to regimen in order to become well, and that they do not
give or sell their medication to others.

Study Significance
Non-adherence to malaria treatment medication continues to impede efforts to eradicate
malaria in sub-Saharan Africa. This randomized controlled trial sought to determine if there was
an association between SMS reminders and pharmacoadherence, as well as exploring the
possible relationship between demographic factors and adherence. This research also sought an
understanding of variables that may be targeted to improve adherence rates, thus addressing
morbidity and mortality related to malaria. As such, it offers opportunity for repetition and
extension to similar studies in this geographical context.

Definition of Terms
Some concepts and definitions used in this research necessitate clarification. Key terms
used throughout this study are defined in Table 2, including the expansion of their conceptual
and operational definitions.
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Table 2: Definition of Terms
Term

Conceptual Definition

Operational Definition

artemetherlumefantrine

A fixed-ratio artemisinin-based
combination of two blood
schizontocides - artemether with
lumefantrine - used for the treatment
of malaria (Bell et al., 2009; White et
al., 2009).

The currently accepted and
effective version of ACT for
P. falciparum malaria in
Zambia as recommended by
the World Health
Organization (WHO, 2012)
and used by Fisenge clinic.

artemisinin-based
combination therapy

A combination of artemisinin or one if The general name used herein
its derivatives with one or more antifor artemisinin-based
malarials of a different class (WHO,
combination anti-malarials.
2006a).

complicated malaria

A confirmed diagnosis of a malarial
infection in an individual presenting
with symptoms of malaria, with
evidence of vital organ dysfunction or
resistance to ACT treatment.
(WHO, 2006a).

Complicated malaria was
assessed by unresolved
symptoms and evidence of
vital organ dysfunction as
determined by clinic nurse.

mHealth

The use of mobile communication
devices to provide health-related
services is referred to as mobile health
or, in short, mHealth (UNF, 2012)

The use of the mobile phone
and SMS messaging.

Medication Event
Monitoring System

An electronic pill bottle cap that
digitally records the time and date of
each opening for later download to a
computer for review and analysis.

The MEMS pill bottle cap
(MWV Healthcare/Aardex
Solution, 501 South 5th St.,
Richmond, VA 23219) used in
this study.

pharmacoadherence

The extent to which an individual
follows a medication regimen that has
been prescribed by the health care
professional in all aspects of the
regimen: timing, dosage, method of
ingestion, etc.

The measurement of
adherence to the ACT regimen
schedule of +/- 1 hour for 2nd
dose and +/- 2 hours for 3rd-6th
doses as measured by MEMS.
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Term

Conceptual Definition

Operational Definition

Plasmodium
falciparum

The genus and species, respectively of
one of the protozoan parasites in the
blood that causes malaria in humans.
Other Plasmodium (P.) species that
cause malaria in humans are P.
malariae, P. ovale and P. vivax
(WHO, 2006a).

Considered the cause of
greater than 99% of malaria in
Zambia as detected by RDTs
(Centers for Disease Control
[CDC], 2014).

rapid diagnostic test

A test to determine the presence of
malaria parasites. An antigen-based,
finger-prick blood stick for malaria in
which a colored line indicates the
presence of plasmodial antigens
(WHO, 2006a). The health care
worker can generally obtain results in
under 30 minutes.

Test used to detect malaria at
Fisenge Clinic: ParaHIT f
RDT by Span Diagnostics,
Ltd. (173-B, New Industrial
Estate, Road No. 6-G, Udhna,
Surat – 394 210, India).

short message service

Another name often used in Africa to
refer to text messaging with mobile
phones.

The intervention used in this
study to send a reminder to the
participant that it was time to
take their medication.

Statistical Package for
the Social Sciences

A computer program that analyzes
and summarizes statistical
information.

SPSS Version 22.0 for Mac
was used for the statistical
analysis.

Theory of Planned
Behavior

A model for understanding and
seeking to change human behavior as
developed by Ajzen (2006).

The theoretical framework
used to guide the current
research intervention.

uncomplicated malaria

A confirmed diagnosis of a malarial
infection in an individual presenting
with symptoms of malaria, without
evidence of vital organ dysfunction
(WHO, 2006).

Positive RDT without
additional symptoms of
complicated malaria.

Preview
This research sought to address the problem of poor pharmacoadherence in malaria
treatment in sub-Saharan Africa. Chapter 2 contains a summary of a review of the literature
pertinent to the problem, identifying gaps in the literature to be addressed by the current study,
10

and introduces the guiding theoretical framework. Chapter 3 details the methods used in the
research, and chapter 4 presents the findings in terms of the sample demographics, group results
and other statistical data from the research. Chapter 5 follows with a discussion of the research
findings, limitations of the study and recommendations for further research.
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CHAPTER TWO: REVIEW OF RELEVANT LITERATURE AND
INTRODUCTION OF THEORETICAL FRAMEWORK
Review of Literature
Introduction
There are numerous studies related to adherence interventions from developed countries,
many of which are associated with chronic illnesses. In addition to having limited relevance to
acute illnesses, these studies are also limited by their cultural context, minimizing
generalizability. An exploration of the state of the science using technology for
pharmacoadherence to a malaria treatment regimen in sub-Saharan Africa was conducted
through a review of the literature. An examination of previous research, including definitions of
adherence, factors influencing adherence and methods of measurement utilized was completed with
focused attention on sub-Saharan Africa.

Methods of Search
A systematic literature review was conducted exploring the use of mobile phones to
improve pharmacoadherence in the context of sub-Saharan Africa. Databases searched included
Cumulative Index to Nursing and Allied Health Literature (CINAHL), MedLine, and Cochrane

Database of Systematic Reviews from 2005-2013. Key terms included cell phone or mobile
phone or mHealth AND adherence or compliance AND health or medication AND Africa or
sub-Sahara or Zambia or community health workers or malaria.
While the upstream (the patient to clinician or clinician to government agency) use of
mobile phones has proven useful in public health programs to monitor disease and communicate
supply needs to suppliers, the focus of this literature review is on downstream (government
12

agency to clinician or clinician to patient) and peer-to-peer (clinician to clinician or patient to
patient) use (Asiimwe et al., 2011; Barrington, Wereko-Brobby, Ward, Mwafongo, & Kungulwe,
2010; Davis et al., 2011; Dean et al., 2012; Kabanywanyi et al., 2010; Kamanga, Moono,
Stresman, Mharakurwa, & Shiff, 2010; Randrianasolo et al., 2010).
Criteria for inclusion were that the article’s context was sub-Saharan Africa and that it
was either associated with pharmacoadherence or that technology was used in a downstream or
peer-to-peer manner for health-related purposes. Studies were limited to those published in the
English language and to current literature due to the recent development of mobile phone
technology.
The search resulted in 30 articles. Of these, two were not health-related adherence; seven
were not in the sub-Saharan African context; four did not involve the use of technology for
adherence and eight were either duplicates or clearly irrelevant. The remaining nine studies were
included in the literature review. In addition, 17 other studies were identified through secondary
searches from the reference lists of selected articles and systematic reviews, resulting in a total of
25 articles. Of these, six were systematic reviews, ten experimental studies, seven observational
analytic studies, one observational descriptive study and one non-research article (see Figure 1
and Table 3).
The remainder of this chapter critically reviews contemporary literature regarding mobile
phone use and adherence in sub-Saharan Africa. There are a growing number of studies in this
context with varying degrees of significance. Following the summary table, a review of articles
regarding ACT adherence is discussed followed by mobile phones used in health in sub-Saharan
Africa. Finally, the two are combined and mobile phone use for adherence is reviewed – first for
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non-malaria diseases and finally for malaria. This section concludes with a summary and a
review of the gaps in the literature.
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Databases searched: CINAHL, MedLine, and Cochrane
Database of Systematic Reviews
Dates: 2005-2013.
Terms: (“cell phone” or “mobile phone” or “mHealth”) AND
(“adherence” or “compliance,”) AND (“health” or
“medication”) AND (“Africa” or “sub-Sahara” or “Zambia”
or “community health workers” or “malaria”)
Initial Results: 30 Articles





Inclusion Criteria
Associated with
health-related
adherence AND
Context: sub-Saharan
Africa AND
Technology was used.

Fail

Pass
9 Included

Add: 16 additional studies identified through
Systematic Reviews and Reference Lists from
initial articles







25 Total results included
6 systematic reviews
10 experimental studies
7 observational analytic
1 observational descriptive
1 non-research article

Figure 1: Algorithm for Literature Review
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•
•
•
•

21 Excluded
2 not health-related
7 not sub-Saharan Africa
4 not technology for
adherence
8 duplicates or clearly
not related

Table 3: Literature Review Summary
Author:
(Year)

Purpose

Bahadur &
Murray
(2010)

Explore use
of cell phone
SMS in
HIV/AIDS
care in South
Africa

Barnighausen,
et al. (2011)

Explore
evidence of
effectiveness
of
interventions
to increase
ART
adherence

Sample
size:
Geographic
context
N/A:
SubSaharan
Africa
(SSA) South
Africa

Type of
study

N/A:
SSA

Systematic
Review
(27 articles
in SSA)

Methodology

Outcome
measures

Systematic
Review
(28 articles
in SSA)

Analysis

Findings

All 6 RCTs in study
found significant
results (p<0.005)
indicating that SMS
improve service
delivery through
reminders (7 studies)
and improve
communication
between community
health workers
(CHW)
More detailed
examination of
evidence needed, but
initial results indicate
SMS can be effective
to increase ART
adherence in subSaharan Africa;
Further research on
theories of adherence
based on behavior
change theories is
needed in SSA
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Limitations

Author:
(Year)

Purpose

Chi &
Stringer
(2010)

To critique
research of
Lester et al.

Cohen et al.
(2012)

Measure
adherence to
ACT (AL)
(over the
counter)

Sample
size:
Geographic
context
Kenya

Type of
study

Methodology

Outcome
measures

Nonresearch

Study of mHealth,
Adherence

N=106
(2 day);
152 (3
day):
SSAUganda

Experimental:
RCT

Patients who
purchased ACT
randomly assigned to
1 of 3 grps: 1. No
follow-up; 2. Followup after 2 days; 3.
Follow-up after 3
days. Measure: # pills
in blister pack or selfreport if unavailable
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3 day:
32.2%
(SD=47) nonadherent; 2%
(SD=14)
probably nonadherent;
65.8%
(SD=48)
probably
adherent.

Analysis

Analysis of
variables
associated
with
adherence:
Probit
regressions
& ordinary
least
squares
regressions

Findings

Little outcome data
available for
mHealth;
Comprehensive
multi-pronged
approach tailored to
local settings is
necessary for
adherence to ART;
Estimate <
$8/yr/patient for SMS
ART adherence
reminders in Kenya
Pharmacoadherence
(PA) to ACT in this
setting = moderate.
Associated variables
at p<0.05:
Some secondary
education 22% more
likely to complete tx
(95% CI [0.063,
0.38]);
Able to read English
had .47 fewer doses
left [-0.93, -0.003]

Limitations

Generalizability; small
sample size;
some selfreport

Author:
(Year)

Purpose

Crankshaw et
al. (2010)

Explore
dynamics and
patterns of
mobile phone
use to
determine
feasibility for
appointment
reminder and
adherence
messages in
ART

Dean et al.
(2012)

To determine
feasibility of
SMS for
adherence to
ART

Sample
size:
Geographic
context
N=300:
SSA South
Africa;
crosssectional

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Observational
analytic

Questionnaires
administered to
sample and results
analyzed

99% willing to
have verbal
mobile
contact;
96% SMS
contact;
# owning
mobile phone:
(n=242; 81%
of sample)

Logistic
regression:
OR,
CI (95%)

Use of cellphone
intervention is
feasible

N=7:
SSA –
South
Africa

Experimental pilot
study

Cell phones were
provided and patients
invited to SMS each
other and clinician re:
HIV, health and
pregnancy. Four postintervention
interviews were
conducted

Collected info
from
interviews.
Overall
satisfaction.

Quantitative
analysis for
usage
patterns;
Qualitative
for themes

Group was satisfied
with the intervention
and participants
recommended that
group be offered in
the future.

Possible
overstatement
of patient
willingness to
receive mobile
phone
reminders due
to courtesy
bias; possible
inaccuracies
due to recall
bias;
generalizability
Pilot study
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Author:
(Year)

Purpose

DeRenzi et al.
(2012)

To decrease
the number of
days that a
CHW is past
due with
routine home
visits using a
combination
of SMS
reminders and
supervisor
informing

Donald et al.
(2007)

Evaluate
mobile
phones in
compliance
use for HIV
patients

Sample
size:
Geographic
context
N=87:
SSATanzania

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Experimental
qualitative

SMS reminders and
promise of supervisor
notification to CHWs
if scheduled home
visits were late;
CHWs questioned
following the studies
regarding the SMS
intervention

Relevant
outcomes
related to
acceptability
on part of
CHWs of
SMS as a
means of
reminding

2 RCTs
statistical
results not
applicable
to the
current
study due
to multiple
interventions;
Follow up
interviews
source of
data
regarding
CHWs
feedback

CHWs expressed
positive feedback to
the use of SMS as
reminders

Non-scientific
study of
responses

N=6:
SSA –
South
Africa

Observation
al analytic
qualitative

Individual interviews
with councilors using
technology 2x 6 mo.
apart

Generally
positive and
strongly
supported

Technology was
found to be easy to
use, eased data
collection, and
reduced fears around
losing notes

Small sample
size,
restricted
setting
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Author:
(Year)

Purpose

Haberer &
Kiwanuda
(2010)

To examine
the feasibility
of using
interactive
voice
response
(IVR) and
SMS for
automated
collection of
weekly
individual
level ART
adherence
data

Sample
size:
Geographic
context
N=19:
SSA –
Uganda;
Crosssectional

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Experimental
mixed
methods

IVR and SMS used to
collect adherence
data from caregivers
of children;
Individual interviews
to assess participants’
impressions of
technologies

Participant
interest and
participation
rates were
high; Weekly
completion
rates low (033%)
Median
adherence
rates:
IVR = 82%
(95% CI [71,
92])
SMS =100%
[99, 100]

Logistic
regression

Use of IVR and SMS
in resource-limited
settings is technically
feasible.
Further research
needed
Associated variables
at p<0.05: No
potential
characteristics
associated with
successful responses

Low power due
to small sample
size and low
weekly
completion
rate; Pill counts
and MEMS
adherence rates
lower than selfreport
suggesting
overstatement
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Author:
(Year)

Purpose

Hoffman et
al. (2009)

To assess the
feasibility and
acceptability
among health
workers and
patients in
using videoenabled
mobile
phones to
monitor
patient
adherence to
TB meds and
to assess
patient
response to
text and video
messages via
mobile phone

Sample
size:
Geographic
context
N=13:
SSA Kenya

Type of
study

Methodology

Outcome
measures

Experimental
quantitative
pilot study

Patients provided
with video- and textready mobile phones.
Asked to video
capture patient taking
dose at home and
transmit to central
database. Also
received health
messages in the form
of video and text
messages on phones

Likert scale
from 1
(Awful) to 5
(Great) rating
satisfaction
with study
procedures
and
technology;
Mean overall
rating: 4.6
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Analysis

Findings

Limitations

All participants
extremely satisfied

Pilot study

Author:
(Year)

Purpose

Horvath et al
(2012)

To determine
whether
mobile phone
SMS
enhances
adherence to
ART in those
with HIV

Husler (2005)

To determine
the effect that
Compliance
Service had
on TB cure
rates and
treatment
completion
rates.
To identify
and describe
social and
economic
impacts.
To assess
Compliance
Service

Sample
size:
Geographic
context
N/A

Type of
study

N=221:
SSA South
Africa

Observational
descriptive;
Retrospective
quantitative
pilot study

Methodology

Outcome
measures

Systematic
review:
Metaanalysis
(243
articles; 17
closely
reviewed; 2
in SSA)

Reviewed patient
records for cure and
completion rates.
Framework used to
examine social and
economic impact.
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Any length
weekly SMS
reminder
lowers risk of
non-adherence
(RR 0.78,
95% CI [0.67,
0.89];
Short weekly
SMS better
than other
lengths (RR
0.77, [0.67,
0.89]
Compliance
service and
records could
not be used to
measure
treatment
adherence
levels due to
poor
implementation
procedures

Analysis

Findings

Limitations

Good evidence that
weekly SMS
reminders are
efficacious for
adherence to ART
compared to standard
care

Insufficient
data for
analysis

Compliance Service
has potential as costeffective system

Many
complications
and obstacles
in the study
severely
limiting
usability

Author:
(Year)

Purpose

Jones et al.
(2012)

To investigate
perceptions
and
experiences of
health
workers
involved in an
RCT to
improve
health worker
malaria case
management
To look at
evidence
regarding the
idea that fixed
or mobile
phones could
be an
effective
health care
intervention
in developing
countries

Kaplan
(2006)

Sample
size:
Geographic
context
N=24:
SSA Kenya

Type of
study

Methodology

Outcome
measures

Observational
analytic
qualitative

Individual interviews
regarding perception
of message
intervention in
Zurovac et al. (2011)
RCT

Frequency,
Length and
Timing:
Positive
Duration:
Positive
Messages:
Positive

N/A

Systematic
review (31
articles; 2 in
SSA)

Analysis

Findings

Limitations

SMS messaging is
acceptable and
effective way of
providing front line
health workers with
active reminders for
care of malaria
patients

Generalizability, small
sample size

Very little literature
on using mobile
telephones in
mHealth for malaria
in low-resource
countries; few
clinical outcomes
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Author:
(Year)

Purpose

Kunutsor et
al. (2010)

To assess the
use of mobile
phones in an
ART cohort
and ascertain
feasibility to
improve clinic
attendance

Sample
size:
Geographic
context
N=276:
SSA Uganda

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Experimental
crosssectional
and
prospective
cohort study

Patients immediately
reminded by voice or
SMS if they missed
appointment; Survey
provided analysis on
adherence to ART;
Adherence support
strategies
implemented and
evaluated

Mean
adherence
levels
assessed
before & after
mobile phone
reminders
Before: 96.3%
(95% CI
[95.2, 97.4]);
After: 98.4%
[97.8, 98.9];
(p<0.01)

Student’s
paired t test

SMS text messaging
and voice calls may
be timely intervention
for patient clinic
attendance, followups and medication
adherence in SSA and
other low income
settings

Generalizability, design
limits ability to
exclude
confounding
factors, design
limits ability to
reliably
conclude
reason for
those who
came back (i.e.
if it was due to
phone
reminder or
not)
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Author:
(Year)

Purpose

Lawford et al.
(2011)

To measure
adherence to
ACT

Sample
size:
Geographic
context
N=918:
SSA Kenya

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Observational
analytic case
study

Patients treated with
AL visited at home 4
days after drug
prescribed; PA
measured by
questionnaire and
blister packs

64.1%
probably
adherent;
31.7%
definitely nonadherent;
4.2% probably
non-adherent

Multivariate
logistic
regression
modeling

Low AL adherence.
Associated variables
at p<0.05:
Patient age >15 cf
<15 (AOR 1.37, 95%
CI [1.02, 1.85]);
Respondent age 2550 cf <25 (AOR 1.65,
[1.10, 2.48]);
>1 day delayed (AOR
0.73, [0.54-0.99]);
Prior drug use (AOR
1.46, [1.08, 1.98]);
Dislikes to
medication (AOR
0.62, [0.47, 0.82]);
>1 correct statement
re: AL (AOR 1.76,
[1.32-2.35])

Generalizability, self-report
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Author:
(Year)

Purpose

Lemma et al.
(2011)

To measure
patient
adherence
levels to 6dose AL
regimen in
treatment of
uncomplicated P.
falciparum
malaria and
identify
factors
affecting
adherence

Lester et al.
(2010)

To determine
if SMS
improves drug
adherence and
suppression of
plasma HIV-1
RNA load as
supported by
blood levels

Sample
size:
Geographic
context
N=155:
SSAEthiopia

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Observational
analytic case
study

Structured
questionnaire
conducted at end of
AL regimen and
blister packs
examined

38.7%
probably
adherent;
34.8%
probably not
adherent;
26.5%
definitely nonadherent;

Univariate
and
multivariate
logistic
regression
modeling

Self-report;
dose timing
info not able to
be accurately
collected

N=538
(SMS=2
73;
Control
265):
SSAKenya

Experimental
RCT

Weekly SMS from
clinic nurse to inquire
about status.
Instructed to respond
within 48 hrs.

RR for nonadherence was
.81, (95% CI
[0.69, 0.94],
p<0.01)
SMS=62%
PA;
Control=50%
PA; (OR 0.57,
95% CI [.40,
.83], p<0.01)

Chi square
test; RR;
OR

Very low adherence
to AL raises serious
concerns for malaria
control in the region.
Associated variables
at p<0.05:
Radio ownership
(AOR 3.8; 95% CI
[1.66, 8.75]);
Belief in traditional
malaria tx (AOR 0.09;
[0.01, 0.78]); Delay
of >1 day in seeking
tx after fever onset
(AOR: 5.39; [1.83,
15.88])
SMS= Significantly
improved adherence
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Self-report,
generalizability

Author:
(Year)

Purpose

Mahmud et
al. (2010)

To offer
CHWs mobile
phones with
SMS as a
means of
communication rather
than the need
for cost and
time in travel

Odigie et al.
(2012)

To determine
the usefulness
of mobile
phones to
improve
cancer care in
low resource
settings

Sample
size:
Geographic
context
N=75:
SSAMalawi

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Observational
analytic
retrospective
pilot study

Group was provided
cell phones and
trained in a variety of
usage (including
patient adherence
reporting,
appointment
reminders…)
FrontlineSMS used to
organize data

2,048 worker
hours and
$2,750 were
saved and TB
tx capacity
was doubled

Calculation,
tallying
and
comparison

mHealth
interventions can
provide cost-effective
solutions to
communication
barriers in the setting
of rural hospitals in
the developing world

N=1176:
SSANigeria

Experimental
qualitative
case study

Cancer patients who
had access to cell
phones were given
the contact info of
oncologist and
encouraged to call
anytime

At 24 months,
97.6% who
had phone
intervention
sustained
follow-up
appointments
vs. 19.2% who
did not

Qualitative

Confirms the value of
the mobile phone to
enhance adherence to
treatment of cancer as
well as infectious
diseases in Africa

No bias
elimination;
costs of initial
capital
investment not
considered;
though
capacity
doubled, no
conclusions re:
outcome
Selection of
comparison
group not
randomized;
generalizability
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Author:
(Year)

Purpose

Onyango et
al. (2012)

To measure
adherence to
ACT; and to
discover
factors in
nonadherence

Sample
size:
Geographic
context
N=297:
SSAKenya

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Observational
analytic
crosssectional
case study
Qualitative:
Individual
interviews

Data on adherence
collected through
interviews; adherence
assessed by duration
of tx and # of tablets
taken in relation to
patient age

Adherence
rate: Age>13
42.1%; Age ≤
13 57.9%;

Multivariate
logistic
regression
analyses;
Qualitative
review

Some demographic
factors affect
adherence; More than
half who get ACT do
not take
recommended dose
and availability is a
concern. Need
programmatic
interventions to
encourage patientcentered care.
Associated variables:
Low age (OR 0.57,
95% CI [0.31, 0.91]
p<0.05);
Higher education
level (OR 0.074,
[0.017, 0.32] p<0.01);
Ability to read (OR
0.29, [0.17, 0.49],
p<0.01);
Higher income
>9,000 Kenya
shillings (OR 0.34,
[0.17, 0.69], p<0.01)

Generalizability; selfreport; malaria
not confirmed;
recall bias
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Author:
(Year)

Purpose

Pop-Eleches
et al. (2011)

To test the
efficacy of
SMS
reminders on
ART
adherence

Sample
size:
Geographic
context
N=431:
SSA Kenya

Type of
study

Methodology

Outcome
measures

Analysis

Findings

Limitations

Experimental
RCT

Participants in
intervention groups
received SMS
reminders either long
or short and sent
daily or weekly

Treatment gp
(SMS)
Adherence
decreased
12% from
weeks 1-12 to
weeks 37-48
compared to
control gp (No
SMS)
adherence
decreased
14% (χ2=7.36,
p<0.01);
53% patients
had >90% PA
with weekly
SMS
reminders vs.
40% patients
without SMS
(p<0.05); 81%
tx
interruptions
exceeding 48
hours with
weekly SMS
vs. 90%
without SMS
(p<0.05)

Chi-square
test &
logistic
regression

SMS reminders may
be an important tool
to achieve optimal tx
response in resource
limited settings

Inconclusive
results; cannot
corroborate
adherence with
viral
suppression;
assumption
that adherence
in 1 tablet =
adherence to
entire regimen
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Author:
(Year)

Purpose

Yeung &
White (2005)

To summarize
current
knowledge on
antimalarial
adherence, the
effectiveness
of
interventions
to increase
usage, and the
effects of
drug
adherence to
therapeutic
response
To assess if
SMS
reminders to
health
workers
improve and
maintain
adherence to
treatment
guidelines for
outpatient
pediatric
malaria

Zurovac et al.
(2011)

Sample
size:
Geographic
context
N/A

Type of
study

N=107:
SSAKenya

Experimental
Cluster RCT

Methodology

Outcome
measures

Analysis

Systematic
Review (24
articles; 13
in SSA)

Findings

Limitations

Overall quality and
quantity of data
available very
inadequate and
results from studies
so variable that
generalizability
regarding level of
adherence to
antimalarials is not
possible

Intervention – all
health workers
received SMS
reminders re: malaria
case-management for
6 months vs. Control
– no SMS
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Correct
management
of AL
improved by
23.7% (95%
[7.6, 40];
p<0.01)
immediately
after
intervention &
by 24.5%
[8.1-41.0];
p<0.01) 6
months later

Descriptive
Differenceofdifferences
effect sizes,
95% CIs &
p values, &
confounding

In resource-limited
settings, malaria
control programs
should consider use
of SMS to improve
health workers’ casemgmt practices

Generalizability

Author:
(Year)

Purpose

Zurovac et al.
(2012)

To review
studies using
SMS for
malaria
control in
Africa

Sample
size:
Geographic
context
N/A:
SSAAfrica

Type of
study

Methodology

Outcome
measures

Systematic
Review (6
articles in
SSA)

Analysis

Findings

Scarcity of peerreviewed studies and
lack of evidence to
determine
effectiveness of SMS
for malaria control;
Suggest 6 areas of
malaria control in
which SMS may
improve delivery of
services and health
outcomes including
pharmaco-vigilance
and patient adherence
to medication
regimens
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Limitations

Results of Search
ACT Pharmacoadherence
The pharmacoadherence rates to ACT in two independent studies in sub-Saharan
Africa demonstrate surprising similarity to each other with a moderate probable adherence
ranging from 64% to 66% (Cohen et al., 2012; Lawford et al., 2011). In contrast, other
studies found that probable adherence fell in the 38-48% range (Gerstl, Dunkley, Mukhtar,
Baker, & Malkere, 2010; Lemma et al., 2011; Onyango et al., 2012). The variance is likely
associated with a stricter definition of probably adherent in the latter three studies, which
considered not only the consumption of all pills, but the timing of consumption as well. This
inconsistency accentuates the failure to achieve comparability in adherence-related
investigations.
Health researchers have attempted to identify factors associated with adherence to
malarial treatment, in order to better identify interventions to improve adherence, and have
had widely varying results. Three studies identified several variables, which are often linked
with a more affluent socio-economic status, that were found to be associated with adherence
including monthly income, education level achieved, radio ownership and literacy (Cohen et
al., 2012; Lemma et al., 2011; Onyango, et al., 2012). Though income, education level and
literacy are easily explained factors, radio ownership has raised some questions. One
possible explanation for association with radio ownership could be exposure to the national
anti-malarial initiatives promoted through the media. Lemma et al. (2011) also identified the
belief that malaria can be treated traditionally (without medication) as a factor associated
with lower adherence. Another factor found in two independent studies in Kenya to be
associated with ACT adherence was age, though the findings appeared to contradict each
other. One study found that younger (<13 years) participants adhered better, while the other
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found that older (25-50 years) participants had better adherence, though the former results
may be related to the attentiveness of the caregiver to ensure that children received
medication (Lawford et al., 2011; Onyango, et al., 2012). Seeking treatment more than one
day after the onset of fever was also linked to adherence although in one study it increased
adherence, while in the other it decreased the adherence rate (Lawford et al., 2011; Lemma et
al., 2011). Lawford et al. (2011) also discovered that several factors related to the patient’s
knowledge and exposure to the drug were significant. The wide range of differences in the
identified factors linked with adherence appears to be due to the inclusion of dissimilar
aspects in studies and/or the disparate definitions of those items studied. Again, lack of
uniformity in definitions and in measurement instruments presents a challenge, limiting
comparability among studies.
While some researchers have focused on finding factors associated with adherence,
others have identified barriers preventing or impeding better rates. Some reasons given for
low rates of pharmacoadherence are forgetfulness and inattentiveness to the regimen
schedule. Two researchers found that symptom reduction and negative side effects
associated with the treatment may also lead to early cessation of the regimen (Morisky et al.,
1986; Jones et al., 2012), while others indicated that early resolution of symptoms resulted in
better adherence rates (Depoortere et al., 2004; Fogg et al., 2004; Yeung & White, 2005).
The search for factors associated with adherence can lead to possible interventions to
improve it. Many of the demographic factors that are linked to adherence such as education,
literacy and income require long-term, socio-economic changes. Recent studies, however,
have been conducted to assess the effectiveness of possible interventions that could be
implemented to produce immediate improvements in adherence such as the presentation and
packaging of the medication. These interventions include a formulation study in which
tablets resulted in 91% adherence compared with only 42% using syrup (Ansah et al., 2001).
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In a packaging study, the dosages that were pre-packaged improved adherence from 60.5% to
82% for tablets and from 32.5% to 54.3% for syrup (Yeboah-Antwi et al., 2001). Provider
instructions in a third study improved adherence significantly from 36.5% when no
instruction was given to 51.9% for pictorial insert only, and to 73.3% for pictorial insert plus
verbal instruction (Okonkwo et al., 2001). These results utilizing simple, low-cost, shortterm interventions offer incentive for further exploration and investigation.
Adherence to malarial treatment continues to present a multi-faceted challenge. The
plurality of factors and results from adherence studies indicate a strong need for further study
and standardization. The rapid expansion of technology offers great opportunity for
innovative research to address some of these areas.

Mobile Health
The recent rise in technology and mobile phone use in Africa offers an unlimited
number of resources for multiple healthcare applications to a wide range of diseases.
mHealth, the common name given to mobile technology used for healthcare, is expanding as
quickly as the technology it utilizes. Studies exploring the patterns of mobile phone use in
sub-Saharan Africa have found the response to the use of cellphones in healthcare to be very
positive and cost-effective (Crankshaw et al., 2010; Dean et al., 2012; DeRenzi et al., 2012;
Donald, Ulrike, Charissa, & Skinner, 2007; Hoffman et al., 2009; Jones et al., 2012;
Kamanga et al., 2010; Odigie et al., 2012). Results indicate that as many as 99% of
healthcare clients were willing to have verbal mobile clinical contact, and 96% were willing
to have SMS contact (Crankshaw et al., 2010). Study participants have cited ease of use and
reduced travel time as primary incentives for mobile phone use (Crankshaw et al., 2010;
Odigie et al., 2012).

34

While some mHealth interventions focus on voice communication, SMS offers the
lowest cost mobile phone approach and therefore one of the best alternatives in a resourcelimited setting. SMS interventions have been used to attempt to improve the delivery of
health services by reminding patients of appointments, assisting with communication
between health care workers, promoting health, improving pharmacoadherence, and offering
accountability (Bahadur & Murray, 2010; Barnighausen, Tanser, Dabis, & Newell, 2011;
DeRenzi et al., 2012; Husler, 2005; Zurovac, 2011).
One pilot study in Malawi measured the effects of SMS communication among
CHWs for purposes such as adherence reporting and appointment reminders. The focus was
on financial and labor hour savings, which were substantial over a 6-month study ($2,750
net; 2,048 hours of worker time), and resulted in an increase in productivity for healthcare
providers (Mahmud, Rodriguez, & Nesbit, 2010).
Other preliminary studies that suggest promising results in the use of SMS utilize
mobile phones for upstream cancer care adherence and downstream reminders to CHWs to
adhere to the prescribed home-visit schedule (DeRenzi et al., 2012; Odigie et al., 2012). One
of these studies discovered that at 24 months, 97.6% of cancer patients who had been given
the contact information of their doctor and encouraged to call had continued with their
follow-up appointments compared with only 19.2% of those who had not been given the
physician’s phone number (Odigie et al., 2012). While the other study had no quantitative
statistical evidence relevant to this study, they received positive feedback to mobile phone
use with CHWs (DeRenzi et al., 2012).
One unique interaction using mobile phones in South Africa connected patients not
only to caregivers, but also to each other, in order to offer community support in a largely
collective society. Pregnant women diagnosed with HIV were invited to use SMS to
communicate with the nurse or with each other about health-related questions and to offer
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one another support and/or advice. The response of the participants to an open-ended
questionnaire was very positive, with patients expressing the experience of
interconnectedness and increased disease-related knowledge (Dean et al., 2012).
Kaplan’s (2006) review of the literature provides evidence that can either support or
refute the hypothesis that phones can be effectively used in healthcare intervention in lowresource countries. The review indicated a gap in the literature regarding the use of mobile
phones to address HIV, tuberculosis, malaria, and chronic conditions in developing countries,
as well as a lack of measured clinical outcomes and quality studies. However by 2012, four
literature reviews noted in this study indicated that research exploring SMS for healthcare is
increasing rapidly. Three of those four reviews (28+ articles) focus on ART adherence with
only a single literature review focusing on antimalarial adherence comprised of a mere six
articles (Bahadur & Murray, 2010; Barnighausen et al., 2011; Horvath, Azman, Kennedy, &
Rutherford, 2012; Zurovac et al., 2012).
These studies represent a broad use of mobile phones and a broad range of results.
Overall results indicate that mHealth is emerging as a potential gold-mine of innovations,
containing limitless applications and opportunity for further research including interventions
to improve pharmacoadherence in general and ACT in particular.

Mobile Phones to Improve Adherence
Non-Malaria
The majority of the research on mobile phone use for adherence in sub-Saharan
Africa focuses on ART adherence in South Africa, a country that is arguably the most
technologically advanced in this geographic context (Bärnighausen et al., 2011; Chi &
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Stringer, 2010; Crankshaw et al., 2010; Dean et al., 2012; Donald et al., 2007; Haberer &
Kiwanuda, 2010; Lester et al., 2010; Pop-Eleches et al., 2011).
Mobile phones applied to pharmacoadherence provide a variety of interaction
methods for communication ranging from SMS on the simple end to virtual DOT via mobile
phone video transmission on the more complex. All of the articles mentioned above include
SMS as one potential intervention, indicating the broad awareness of the growing
possibilities and affordability of this simple application.
Often SMS is explored in parallel with other interventions. One innovative study
used both IVR and SMS to collect adherence information from caregivers of children
infected with HIV in Uganda. This qualitative study determined that, while the rates of
interest and participation were high, the completion rate for questionnaires was low (0-33%)
possibly because of the new nature of IVR in this cultural setting. This was the only study
found in sub-Saharan Africa using IVR for medication adherence. The authors suggest that
the use of IVR and SMS is technically feasible, however setup costs for more complex uses
of technology such as IVR need to be considered and may prove prohibitive in resourcelimited settings (Haberer & Kiwanuka, 2010).
Most research regarding mobile phones and adherence utilized the cheapest, simplest
and most common means of communication via mobile phone - SMS or simple phone calls –
to remind the patient directly to take their medication. Kunutsor et al. (2010) addressed
medication adherence indirectly by reminding patients through voice and SMS about missed
clinic appointments, which included the patient picking up their medication refills.
Adherence levels were assessed to determine the effect of reminders on optimal adherence.
Mean adherence was determined to be significant with 96.3% before and 98.4% after mobile
phone intervention.
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Two systematic reviews were found to specifically explore mobile phone use in subSaharan Africa associated with ART adherence (Bärnighausen et al., 2011; Horvath et al.,
2012). Within these reviews, two RCTs from Kenya compared the adherence of those with
SMS communication to those without SMS. In both studies, the use of a short weekly SMS
reminder resulted in improved rates of adherence (53-62%) when compared to the control
group without reminders (40-50%). In addition, one study explored the effectiveness of
different lengths and frequencies of SMS. Both studies found that SMS reminders were
associated with increased adherence, and a short weekly SMS was found to be more effective
than other lengths and frequencies (Lester et al., 2010; Pop-Eleches et al., 2011). Findings
also included a decrease in treatment interruption in those receiving weekly reminders (81%)
compared with the control group (90%) (Pop-Eleches et al., 2011). There is significant
evidence validating the use of SMS reminders to increase adherence to ART in sub-Saharan
Africa, however Chi and Stringer (2010) suggest that a multi-faceted approach tailored to
local settings may prove more effective than any single intervention.
Studies using mobile phones for adherence are not restricted to HIV medications nor
are they limited to low-tech applications of mobile phones. Hoffman et al. (2009) conducted
a pilot study in Kenya to assess the feasibility and acceptability of mobile phones to monitor
TB adherence through upstream video reporting. They offered video-enabled mobile phones
to 13 patients, and trained a health care assistant in the home to video the patient taking their
TB medication. These data were then immediately transmitted to a central database where
healthcare workers observed them as required by DOT protocol. The investigators also sent
video and SMS health messages downstream to the patients. The patients completed a brief
questionnaire at intake, after 15 days and at one month after intake asking them to rate their
experience. The results indicated a mean response of 4.6 on a 5-point Likert scale from 1
(“Awful”) to 5 (“Great”) suggesting that participants were very satisfied with study
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procedures and technology. Mobile phone technology is becoming a viable alternative to
direct observation offering a virtual DOT in some areas where mobile phone videos can be
sent.
One service in South Africa sends SMS downstream to patients to remind them to
take their TB medication according to regimen. One pilot study of the company evaluated
the use of the reminder service on TB recovery to identify socio-economic impacts of
technology in that context, and to conduct an assessment of the management of the project.
While the treatment outcomes involving the SMS intervention were comparable to clinical
outcomes, the results were not statistically significant. Nevertheless, the authors conclude
that the use of SMS for medication reminders offers a cost-effective potential resource to
complement clinical care (Husler, 2005).
Much of the non-malaria research utilizing mobile phones for adherence has
implemented similar techniques using SMS direct to patients for reminders and many of them
offer hope for achievable wide-spread results. Studies have not produced statistical
significance across the board, but many suggest promise for new implementations and
continued research.

Malaria
Only six studies were found using SMS for malaria control in Africa with five of
these focusing on upstream uses such as disease surveillance or commodity monitoring
(Zurovac et al., 2012). The only RCT discovered using downstream SMS reminders for
malaria treatment in sub-Saharan Africa is that of Zurovac et al. (2011) in which SMS are
sent to CHWs.
In more developed nations, a team of health care professionals including nurses,
physicians and pharmacists conducts the role of health care. In sub-Saharan Africa, CHWs
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or medical assistants (comparable to a nurse practitioner) function independently, diagnosing,
prescribing and monitoring treatment, generally with no involvement from others (Rueda,
2008). Resource-intensive interventions directed towards the individual have been
considered difficult to implement in sub-Saharan Africa due to the large numbers of patients
and limited number of health providers (Safren et al., 2012). Therefore, research to date has
focused primarily on adherence interventions to the provider of the medication.
The Kenyan study conducted by Zurovac et al. (2011) assessed the effectiveness of
SMS malaria case-management reminders from primary investigators (PI) to HCWs in
promoting adherence to standard malaria treatment. While the standard care protocol for
malaria is relatively simple, it is challenging to ensure that practice conforms to the standard,
so SMS messages consisting of educational reminders related to the ACT regimen were sent.
The study revealed an improved adherence to medication guidelines by 23.7% immediately
after intervention, with a 6-month improvement rate of 24.5%. In a follow up article to the
RCT, Zurovac et al., (2012) confirmed that non-adherence is a major area of deficiency in the
treatment of malaria, and they support the idea that SMS is potentially beneficial in
increasing pharmacoadherence. In a qualitative study examining Zurovac’s research, the
authors found that there was a high acceptance of all the aspects of the intervention using
SMS as reminders to bring about behavioral change (Jones et al., 2012).
While the research of Zurovac et al. (2011) and Jones et al. (2012) involved SMS to
malaria HCWs rather than the patient, Lester et al. (2010) and Pop-Eleches et al. (2011) have
also demonstrated that SMS interventions directly to the patient can be effective, though their
research focuses on ART adherence. No studies were discovered that utilized SMS directly
to patients for ACT pharmacoadherence in sub-Saharan Africa indicating a significant gap in
the literature and research. The current study offers an attempt to address this gap and
change adherence behavior.
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Theoretical Framework
Introduction
The National Malaria Control Center of Zambia states that the primary goal of the
national communication strategy “…is to facilitate positive behavior change (emphasis
added) and capacity building through the provision of correct and relevant information to
empower people for more effective decision-making in health” (National Malaria Control
Center, 2012, “Behavior Change” para. 2). Addressing the many factors affecting adherence
can be overwhelming, however the singular focus is on changing behavior. If one’s behavior
in taking medication can be altered, pharmacoadherence rates can be improved. A theory
addressing the needed change is essential to underlie continuing attempts to improve health
habits.
The theoretical framework underlying the suggested intervention is the Theory of
Planned Behavior. The Theory of Planned Behavior (TPB) is a social cognitive model
credited to Icek Ajzen as an extension of his and Fishbein’s Theory of Reasoned Action, and
incorporates aspects of Bandura’s Theory of Self-Efficacy (Ajzen, 1988; Fishbein & Ajzen,
2010; Kuhl & Beckman, 1985). This theory (see Figure 2) provides the most relevant
framework for implementing the targeted intervention for improving antimalarial
pharmacoadherence through planned behavioral change using SMS messages.
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Figure 2: Theory of Planned Behavior
Adapted from “Theory of Planned Behavior,” by Icek Ajzen, 2006, retrieved from Icek
Ajzen, TPB, http://people.umass.edu/aizen/tpb.diag.html. Used by permission as stated on
website.
The TPB postulates that there are three constructs that guide behavior. The first
construct is that of behavioral beliefs, involving the individual’s beliefs about the expected
outcomes of a particular behavior. The collective behavioral beliefs result in a particular
favorable or unfavorable attitude towards the behavior. The second, normative beliefs,
focuses on the perceived expectations of significant others and one’s motivation to meet
those expectations. The collective normative beliefs comprise a subjective norm or social
pressure to behave or not to behave in a certain manner. The third and final construct, control
beliefs, measures the perception of factors that may facilitate or inhibit this behavior, and the
perceived power inherent in those factors. Collective beliefs about control result in a
perception of the amount of control one has over one’s own behavior. The sum of these three
outcomes – behavioral attitudes, subjective norms and perceived control - results in a level of
intention, which, if sufficiently significant, generally results in the desired behavior.
Increasing any one of these constructs increases the level of intention, which in turn increases
the likelihood of the individual carrying out the behavior (Ajzen, 2006).
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For an intervention using TPB to be successful in the long term, it will likely focus on
one or more of the factors that affect the intention and therefore the behavior: Attitude
toward the behavior, subjective norms and/or perceived control over behavior. Because each
of these is grounded in corresponding beliefs, the most effective and lasting change will
address the belief system itself, though this is also the most difficult level to address and
involves prolonged commitment to change (Ajzen, 2006). This theory has great potential for
long-term future research and exploration of beliefs and attitudes to discover factors affecting
pharmacoadherence for malaria treatment in Zambia. The current intervention, however,
offers a short-term method for addressing one aspect of the theory through focusing on
barriers that limit actual behavioral control.
While perceived control is a critical element in the TPB, there can be barriers to the
execution of a behavior, making actual control less than perceived control. These barriers
may interrupt one’s intention, preventing the individual from carrying out the behavior. This
limit on volitional control indicates that the actual control that one has over a behavior, rather
than merely the perceived control, is what determines the resultant action (Ajzen, 2006).
While the TPB offers a sound framework for interventions to promote pharmacoadherence,
some concerns and opposition appear in the literature.

The SMS Intervention within the Theoretical Model
Patients generally believe that they control their ability to adhere (control beliefs).
The patient’s beliefs lead to the perception that they can and will have control to adhere to the
prescribed regimen because of their desire to be well, and the perception of the benefits of
good health (perceived behavioral control).
When focusing on the right hand side of the TPB model (see Figure 3), it is evident
that an individual’s likelihood of engaging in adherent behavior correlates with the strength
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of the intention to actually adhere, assuming that barriers do not prevent the intention from
resulting in actual adherent behavior. Barriers interfere with, and therefore decrease actual
control. Some of the barriers to regimen adherence that are identified in the literature review
are: Forgetfulness, the medication having a bad taste, the negative side effects (e.g. nausea,
vomiting) caused by the medication, and tendency to quit taking the medication when
symptoms subside. The intervention of SMS used in this study sought to overcome some of
the barriers to adherence by providing both a reminder to address forgetfulness and
encouragement to complete the regimen. In addition, the study included a short questionnaire
collecting information that may prove helpful in the more difficult task of initiating long-term
change in beliefs that can bring about deep-seated, long-term change in behavior.
SMS Intervention

Barriers preventing
perceived behavioral
control from becoming
actual behavioral control

Figure 3: Detail of Figure 2: SMS to Address Barriers
Adapted from “Theory of Planned Behavior,” by Icek Ajzen, 2006, retrieved from Icek
Ajzen, TPB, http://people.umass.edu/aizen/tpb.diag.html. Used by permission as stated on
website.
Critique of the TPB
While no objections specifically to the TPB for pharmacoadherence in sub-Saharan
Africa were discovered, some general objections to the efficacy of the model exist. Ogden
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(2003) expresses several concerns: He posits that models of social cognition cannot be tested
because they cannot be proven false; he insists that the relationships between the model
components are true by definition, therefore ensuring a strong correlation; he asserts that the
questionnaires to test the constructs might actually cause and influence cognitions that impact
behavior rather than merely assessing them.
The TPB would, however, be proven false if all three constructs of the model failed to
predict intention, which research has not indicated (Ajzen & Fishbein, 2004). The constructs
have been validated in equation analysis and in other investigations that have tested the
validity of the construct, and the evidence indicates that assessment methods do not
significantly affect the cognitive constructs in the TPB (Ajzen & Fishbein, 2004).
Some critics question the assumptions of all reasoned action theories, a category into
which the TPB falls. Wegner (2002) doubts the significance of consciousness as an agent of
causation. Greenwald and Banaji (1995) believe behavior to be driven by implicit attitudes
while others (Aarts & Kijksterjuis, 2000) suggest that behavior is a result of other mental
processes, of which a person is not conscious. These objections do not lend themselves to
clear empirical verification.
Critics also claim three other limitations of the model. Some researchers question the
sufficiency of the model or suggest that the limits inherent in it are too great. Another of the
criticisms of TPB is that it does not account for affect and emotions, that the model is too
rational, while yet another argument suggests that the TPB is not sufficient to explain
behavior. Critics claim that other components should be added, but rarely agree about which
component(s). Ajzen (2011) addresses these concerns.
Regarding the limits of predictive validity in terms of correlations among constructs,
the best that can be reasonably expected in this type of model is around 0.6, a measure that
approximates the results in the studies he references.
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The TPB does not assume that beliefs are formed rationally. The “planned” nature of
the behavior does not refer to a rational belief basis, but rather to the nature in which beliefs
lead to attitudes that influence intention and, ultimately, impact behavior. Affect and
emotions serve as foundational factors to beliefs, and as influencers to direct which beliefs
within our memories affect one’s attitude or intention (Ajzen, 2011).
Ajzen and Fishbein (2004) expect further developments in the model and provide
guidance for the criteria that any additions would need to meet, while rejecting any specific
additions proposed to date based on failure to comply with said criteria.

Population of Interest
One of the primary objections is that the TPB is individualistic and therefore not
applicable to more communal societies such as those found in sub-Saharan Africa (Campbell,
2003; Kagee & van der Merwe, 2006). Fishbein (2002) indicates that, when properly
applied, this model is in fact sensitive to cultural differences, since it incorporates the belief
system of the population being observed. For example, communal influence would be
addressed in the TPB in the normative beliefs construct.
Since there is room within the model for considering cultural differences, applying the
TPB to pharmacoadherence in sub-Saharan Africa has integrity. In one study in South
Africa, TPB significantly explained variance in patients’ intentions and behavior related to
adherence. TPB variables explained 47% of the variance in adherence intentions, resulting in
a large effect (Kagee & van der Merwe, 2006; Polit & Beck, 2004). When combined,
attitudes and perceived behavioral control explained 23% of the self-reported
pharmacoadherence variance. While TPB was found to only explain a portion of adherence
intentions in the sample, the strongest predictor of pharmacoadherence intentions was
perceived behavioral control (β=0.59), indicating that improving the perception of behavioral
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control may be an effective way to increase pharmacoadherence (Armitage & Conner, 2001;
Kagee, 2008). Offering the patient a reminder by SMS is likely to increase the perception of
behavioral control as well as to overcome the barrier of forgetfulness thus increasing actual
behavioral control. The end result would be an increased probability of the desired behavior.
The TPB provided a sound theoretical model for the current research.

Summary of the Literature Review and Theoretical Framework
Overall, the literature review indicates that SMS is efficacious in enhancing
pharmacoadherence, offering the potential to be effective in malarial treatment in subSaharan Africa and hence result in a greater recovery rate and decreased drug-resistance. This
innovation is a powerful method to disperse information, offering an effectual, simple and
low-cost application of technology to reach a population in a timely and efficient manner
(Gardner et al., 2007; Zurovac, et al., 2011). Nevertheless, the use of SMS to initiate
behavioral change in health is in the early stages of exploration, and there is very little
evidence-based research of the use of this technology directly to patients to address
pharmacoadherence behavior in sub-Saharan Africa (Hampton, 2012; Zurovac et al., 2011).
No studies were found using this specific application for malaria. This inspires continued
attention to this area of research.
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CHAPTER THREE: METHODS
Introduction and Design
This chapter presents the methods used in this study beginning with the design,
sample and setting, population and inclusion/exclusion criteria. In addition, the precautions
for working with human subjects are identified and the intervention and instruments used are
explicated. Finally, the procedures and the statistical analysis for the study are described.
This prospective, quantitative, randomized controlled trial was an experimental,
between-groups design. Pharmacoadherence was the dependent variable and the SMS
intervention was the independent variable.

Sample and Setting
The convenience sample was comprised of individuals who presented to the public
clinic in Fisenge, Zambia, tested positive for uncomplicated P. falciparum malaria, and met
inclusion criteria. The setting for this study was the rural village of Fisenge, Zambia located
just off the Luanshya Road close to the Ndola/Kitwe road in the Copperbelt Province.
Fisenge has a population of 13,000 with a household income below the national average of
USD $1,200/year (Zambia Census of Population and Housing, 2000). Fisenge is
representative of rural villages in the Copperbelt Province, with the majority of citizens
educated in the public schools where, up until 2014, all education was delivered in English.
This site was chosen based on the large number of patients diagnosed with malaria according
to clinic records during a site visit in 2012.

Population
The target population of this study was rural Zambians over 18 years of age who were
at least minimally literate in English, and who were diagnosed with uncomplicated P.
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falciparum malaria. Literacy is defined by the United Nations as being able to read and write
a short and simple statement about every day life, a definition that 70% of Zambians meet
(United Nations Development Programme, 2011). The term “minimally literate” used in this
study indicates an ability to read sample phrases, which are similar to those that were sent by
SMS.

Inclusion/Exclusion Criteria
To be included in the proposed study, participants must have been at least 18 years of
age; had continuous access to a mobile phone for the three days following their clinic visit;
were able to communicate via SMS; and were able to read three health-related phrases
chosen from a selection of those that were sent by SMS. Participants were excluded if
another member of the household was already a part of the study. In addition, if potential
subjects had been treated for malaria in the two weeks immediately prior to their
presentation, they were excluded. While the original exclusion criteria also included a
recorded fever more than 24 hours before clinic visit in order to avoid complicated malaria
cases, none of the participants had records of fever measurement.

Sample Size
For the purpose of this study, a medium effect size for a Chi-square analysis and
bivariate linear regression was assumed for the intervention. An apriori power analysis was
conducted using G*Power (ver. 3.1.6) to determine sample size to provide a medium effect
size (.30), with a level of significance of α = .05, and power of .80 (Cohen, 2003; Faul,
Erdfelder, Lang, & Bucher, 2009). The computation resulted in a required sample size of 88.
A targeted sample size of 126 was determined to allow for attrition and incomplete data.
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Ethical Considerations
Protection of Human Subjects
Provisions to insure safety of participants were maintained through the adherence to
legal and ethical institutional review board (IRB) policies of the University of Central Florida
(see Appendix F), as well as those of the Tropical Diseases Research Centre (TDRC) in
Ndola, Zambia (see Appendix G) as directed through the Zambia Ministry of Health (see
Appendix H). The TDRC prospectively agreed to serve as an external collaborator to support
the research (See Appendix I).
Minimal risk was present for participants. The only risks from participation in the
study were those involved with travel back to the clinic to return the electronic pillbox. A
return trip to the clinic for a post-treatment reevaluation is already one aspect of the current
standard of care, though compliance is rare. All other risks - physical, psychological, social,
legal and economic - were minimal in probability, magnitude and duration.
Confidentiality can also be a concern in studies involving human subjects. The SMS
interventions in this study did not jeopardize confidentiality since the SMS intervention did
not address the individual by name, nor did it include any information about the patient. In
addition, malaria carries no stigma in Zambia. Within the Zambian culture, illness and
medicine are treated very differently than in western world. There is some stigma associated
with leprosy and sexually transmitted diseases, but with the clinic being a communal place,
where gathering neighbors discuss their illnesses, and with malaria being extremely common,
this diagnosis does not necessitate confidentiality (J. J. Enright, personal communication,
June 23, 2014).
The collection of data was communicated from the assistant directly to the PI, who
entered the information by patient number rather than name on a secure, password-protected
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computer accessible only to the PI. Numbers were generally assigned in the order in which
they presented to the clinic. Paper documents that link the name and the patient’s number
were stored in a locked file cabinet in the PI’s secure house. The paper documents were
destroyed at the conclusion of the presentation of the study findings. Data will be stored
indefinitely but without patient identifiers. The PI will not use names or other patient
identifiers when communicating data or results. The SMS intervention did not address the
individual by name nor did it include any information about the patient.
There were no study-related costs to participants, and all costs for the electronic
pillbox product were borne by the investigator. No transportation costs were required from
the patients since the primary method of access to the clinic is by foot. There was a small
risk that participants involved in the study could have been bothered by the SMS reminders.

Benefits to Human Subjects
Potential benefits to the individual participants included a higher likelihood of
adherence and therefore more successful treatment for malaria. The possible benefits to the
community from a decrease in resistance are substantial and public policy could potentially
be impacted. In addition, the phone card offered in appreciation for participation benefitted
those in the study.

Intervention
The intervention used was a series of SMS messages in English (see Appendix A)
sent directly to the participant by the PI at the times that the regimen prescribed the malaria
medication was to be taken. These SMS messages were to remind and encourage them to
take their medication at that time. The content of the messages varied slightly, but each
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addressed the taking of the medication and, when the last dose was due, the SMS stated that it
was the last dose.

Instruments
The ParaHIT f RDT used in this research was manufactured by Span Diagnostics Ltd.
WHO recommends a minimum standard of 95% sensitivity and 95% specificity for P.
falciparum densities of 100/μl (WHO, 2006b). Independent research evaluating this RDT
resulted in a 97.6% (95% CI [95.6, 98.8]) sensitivity and 87.7% [83.0, 90.6] specificity, and
concluded that it performed well, was appropriate for field use and can contribute to effective
diagnosis of malaria (Guthmann et al., 2002). The manufacturer’s literature indicates a
sensitivity of 99.42% [98.3, 100] and a specificity of 99.59% [99.2, 100] (Span Diagnostics
Ltd., 2013). Differences in results may be attributed to improvements in the RDT in recent
years. A study of the average 2012 weighted cost for RDTs in Zambia was $0.31 (USAID
Deliver Project, 2012). Since RDTs are provided free of charge to government clinics in
Zambia, there was no cost in the current study for the diagnostic tools.
Although the PI’s and the participants’ phones were used to communicate via SMS,
the only new instrument that was introduced into the study that was not standard care was the
MEMS. As discussed in the literature review and despite the limitations, the MEMS is
considered the imperfect gold standard in pharmacoadherence measurement where direct
observation is not feasible.

Procedures
Research Assistant
The PI selected and hired a female research assistant after significant screening of
potential applicants. Qualifications included the completion of high school and fluency in
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Bemba, the local language, and English, the national language. The assistant was trained to
interview potential participants, collect demographic data and educate the patient regarding
the medication regimen. She also completed Collaborative Institutional Training Initiative
(CITI) Training as required by the University of Central Florida under the supervision of the
PI.

Recruitment
The clinic nurse identified a potential participant through observational use of
inclusion criteria, and referred him or her to the assistant. The assistant then established the
eligibility of the individual as a participant using inclusion/exclusion criteria, described
details of participation, including the voluntary nature of the study and the incentive offered,
and inquired regarding their willingness to participate. If the individual was willing to take
part in the study, the assistant obtained permission to record the conversation, educated the
participant regarding the regimen, and obtained consent through signature on an Invitation to
Participate which was printed in English (see Appendix B). Information sessions were
conducted in English, the national language of Zambia. Participants received a copy of the
study information form for their records. The assistant’s interaction with patients was audiorecorded, transcribed and randomly assessed for fidelity. These recordings were destroyed
upon completion of transcription and aggregation.

Demographics and End-of-Study Questionnaire
After consent was obtained, the assistant collected baseline demographic data and
illness characteristics using a questionnaire (see Appendix C) designed for this study, which
included demographic variables that were found in the literature review to be associated with
adherence. The demographic questionnaires had the patients’ names removed when they
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returned the electronic pillbox for human subject protection. All participants were asked a
question as part of the end-of-study questionnaire when they returned the electronic pillbox
that addressed the awareness of the existence of the other group in order to analyze for the
possible effect of contamination.

Pilot Study
The first ten patients recruited comprised a pilot study to determine whether
adjustments to the study were needed and to refine procedures before completing the study.
The pilot included analysis of the use of the electronic pillbox and a determination of which
SMS messages were most appreciated through an end-of-study questionnaire. Adjustments
were made as necessary, and those in the pilot study who needed no adjustments are included
in the full and final sample.

Random Assignment
Each participant was randomly assigned to either the intervention group or the control
group by block randomization through an envelope system.

Participant Instructions
The research assistant verbally instructed all participants on the treatment regimen.
Patients were educated regarding the need to take medication with food, and, if vomiting
occurs within one hour of the ingestion, to take the next dose and obtain a replacement dose
from the clinic. The healthcare provider administered the first dose of the medication in the
clinic with the research assistant observing. The assistant reviewed pictorial instructions and
provided the remaining nurse-prepared medications per clinic protocol in perforated foil
blister packs containing a 4-pill dose each. These were inserted into an electronic pill bottle
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with a MEMS cap (see Appendix D), along with written instructions regarding the regimen.
The MEMS cap on the pillbox containing the ACT electronically recorded the time of each
opening of the medication bottle beginning with the first dose. The participant was instructed
to return between three days and one week from the distribution date with the electronic
pillbox for a health re-evaluation. A pre-paid phone card with 20 kwacha (approximately
$3.50) of talk time was presented in appreciation for participation when the bottle was
returned.
If the participant was in the control group, the assistant released him/her. If the
participant was in the intervention group, the SMS communication was described and
reviewed if necessary. The assistant then released him/her and initiated the SMS intervention
sequence.

SMS Intervention Sequence
The PI generated an SMS reminder to the participant at the prescribed time each dose
of the medication was to be taken - 8 hours after the initial dose and at the prescribed times of
8 a.m. and 8 p.m. for the subsequent 2 days of the regimen (see Appendix A).

Conclusion of Participation
When the participant returned the electronic pillbox, the data were transferred to a
designated, secure computer and entered into IBM Statistical Package For The Social
Sciences (SPSS) for review and analysis. If the bottle was not returned within one week, an
SMS reminder to return the bottle was sent. If the bottle was not returned within the
following three days, the assistant followed up with a community visit to collect the bottle
and assess the patient’s health. The participant was offered a Debriefing Statement following
the return of the MEMS (see Appendix E).
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Pharmacoadherence Measurement
Pharmacoadherence was measured by comparing electronic pillbox openings to the
prescribed times of the treatment regimen. Adherence was defined as having an
electronically recorded bottle opening within one hour of the prescribed time for the second
dose (8 hours after initial dose), and a recorded bottle opening within two hours of the
prescribed time for the next two days’ doses (8 a.m. and 8 p.m. on each day) based on dosage
recommendations (Lefevre et al., 2001; WHO, 2012). The completion of the regimen was
verified by a final pill count (target = 0). If the recorded bottle opening times fell within the
designated ranges and the pill count was 0, the patient was considered probably adherent. If
either requirement is not satisfied, they were classified probably non-adherent.

Statistical Analysis
Once all data were collected and summarized, the data were screened for
completeness. The PI compared the proportion of those determined to be probably adherent
in each group to those determined to be probably non-adherent, and a Pearson Chi-square
test of independence was conducted to determine association between SMS reminders and
pharmacoadherence. In addition a Chi-square test of homogeneity was conducted to ensure
uniformity of the two groups. Finally, binary logistic regression was used to control for all
demographic covariates and determine any factors associated with adherence.
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•
•
•
•

Assessed for eligibility from Fisenge Clinic
Adult (≥18 yrs)
Have cell phone available/SMS capability
Able to read three health-related phrases
Confirmed malaria (RDT)


Target Enrollment n=88
(Assuming attrition of
25%, target at n=126)










•
•
•
•

Exclusion criteria
Not meeting inclusion
criteria
Recorded fever > 1 day
prior
Malaria treatment in past
2 weeks
Household member
already participating

Education
Permission to audio record
Instruction on regimen/pillbox
First dose administered
Electronic pillbox with medication distributed

Allocated to control
group
 Standard of Care +
Electronic Pillbox
 Patient released







Enrollment
Details of
participation given
Incentive explained
Consent obtained
Demographic data
collected

Block Randomization

Allocation through
envelope selection system

Allocated to intervention
group (SMS)
 SMS described & ability
assessed
 Mobile phone info &
regimen entered into PI’s
mobile phone for
reminders to be sent (8
hrs after initial dose + 8
a.m. and 8 p.m. for
remaining 2 days)
 Patient released

Data Collection & Analysis
Pillboxes returned within 3 days-1 week or follow-up initiated
Data on pharmacoadherence uploaded
Data screened for completeness
Data analyzed for association between SMS and pharmacoadherence
Logistic regression to control for contamination and other association

Figure 4: Experimental Methods
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Assessed for eligibility (n=155)

Excluded (n=42)
 Not meeting inclusion
criteria (n=39)
 Declined to participate
(n=3)

Randomized

Allocation
Allocated to intervention (n=58)
 Received allocated intervention
(n=57)
 Did not receive allocated
intervention because malaria
became complicated (n=1)

Allocated to control (n=55)
 Normal control group (n=54)
 Malaria became complicated
(n=1)

Analysis
Analysed (n=48)
Excluded from analysis (n=9)
 Conflicting instructions (n=4)
 Malfunctioning MEMS cap (n=1)
 MEMS caps not returned (n=4)

Analysed (n=48)
Excluded from analysis (n=6)
 Malfunctioning MEMS cap (n=2)
 MEMS caps not returned (n=4)

Figure 5: Consort Flow Diagram
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Summary
In summary, this chapter reviews the methods used in this study including the design,
sample and setting, ethical considerations, procedures and statistical analysis. The methods
reviewed are considered appropriate and feasible for the current study to determine the
association between SMS reminders and pharmacoadherence.
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CHAPTER FOUR: RESULTS
MEMS cap and demographic data were collected over a 2-month period and analyzed
using IBM SPSS for Mac version 22.0. All records used in the sample were complete with
no missing data.

Characteristics of the Study Population
The study population consisted of those who met inclusion/exclusion criteria at
Fisenge clinic from February 21 through April 26, 2014. Though the targeted sample size
was 126, data collection was stopped at 113 as more than 88 (target sample size) were able to
be included in the analysis. Of these, three were excluded because of malfunctioning MEMS
caps; two because their malaria became complicated and they transitioned to alternative
treatment; four because of conflicting medication instructions between the clinic staff and
research assistant; and eight because the assistant was unable to collect the MEMS cap. The
remaining 96 (85%) consented to participate, were randomized to the control or intervention
group, and their data were analyzed.
Among participants, 52.1% (n=50) were males and 47.9% (n=46) were females. The
participants ranged in age from 18-64 with 32.3% (n=31) of the sample aged 18-25; 28.1%
(n=27) aged 26-35; 24.0% (n=23) aged 36-50; and 15.6% (n=15) over 50. A large number of
these were unemployed (61.5%, n=59) and/or had income less than 500 Kwacha rebased
(Kr)/month (USD $75) (75%, n=72). Additional demographic information is presented in
Table 4.
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Table 4: Summary of Demographic Characteristics
Variable

Response

# (%)

Age

18-25
26-35
36-50
Over 50

31 (32.3%)
27 (28.1%)
23 (24.0%)
15 (15.6%)

Gender

Male
Female

50 (52.1%)
46 (47.9%)

Residence

Village
Rural

65 (67.7%)
31 (32.3%)

Family income

0-100 Kr
100-500 Kr
500-1000 Kr
> 1000 Kr

63 (65.6%)
9 (9.4%)
17 (17.7%)
7 (7.3%)

Employed

Yes
No

37 (38.5%)
59 (61.5%)

Own radio

Yes
No

69 (71.9%)
27 (28.1%)

Languages able to write

English
English and Bemba
English and Other
English, Bemba and Other
Bemba

6 (6.3%)
53 (55.2%)
5 (5.2%)
29 (30.2%)
3 (3.1%)

Languages able to read

English
English and Bemba
English and Other
English, Bemba and Other
Bemba

5 (5.2%)
57 (59.4%)
5 (5.2%)
29 (30.2%)
0 (0%)

Highest grade completed

1-7
8-9
10-12
College

22 (22.9%)
31 (32.3%)
32 (33.3%)
11 (11.5%)

Taken malaria med before

Yes
No

87 (90.6%)
9 (9.4%)

Belief in traditional tx
(i.e. without medication)

Yes
No

4 (4.2%)
92 (95.8%)
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Groups
Of the total sample (N=96), block randomization resulted in 50% (n=48) assigned to
the control group and 50% (n=48) to the intervention group. After reviewing the data, some
variables (age, income, education) were collapsed to increase the n for analysis, and a Chisquare test of homogeneity conducted. Where the Chi-square assumption was not met, the
Phi value was used. The analysis verified that the randomization successfully achieved
balance across observable characteristics with the two groups not differing significantly in
any categories (p>0.05) (see Table 5).
Table 5: Chi square test of homogeneity
Variable
Age

Response
18-35
Over 35

Intervention
Group
31 (64.6%)
17 (35.4%)

Control
Group
27 (56.3%)
21 (43.8%)

Gender

Male
Female

21 (43.8%)
27 (56.3%)

29 (60.4%)
19 (39.6%)

.102

Residence

Village
Rural

30(62.5%)
18 (37.5%)

35 (72.9%)
13 (27.1%)

.275

Family income

0-500 Kr
> 500 Kr

36 (75.0%)
12 (25.0%)

36 (75.0%)
12 (25.0%)

1.00

Employed

Yes
No

16 (33.3%)
32 (66.6%)

21 (43.8%)
27 (56.3%)

.294

Own radio

Yes
No

31 (64.6%)
17 (35.4%)

38 (79.2%)
10 (20.8%)

.112

Highest grade
completed

1-9
10-College

26 (54.2%)
22 (45.8%)

27 (56.3%)
21 (43.8%)

.837

Taken malaria med Yes
before
No

43 (89.6%)
5 (10.4%)

44 (91.7%)
4 (8.3%)

.726

Belief in
traditional tx
(i.e. without
medication)

2 (4.2%)
46 (95.8%)

2 (4.2%)
46 (95.8%)

1.00

Yes
No
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p value
.404

Findings
Pilot Study
Only one adjustment was made following the pilot study. The PI discovered that the
clinic nurse was prescribing second and third day dosages at 6 a.m. and 6 p.m., and the SMS
reminders were being sent at 8 a.m. and 8 p.m. as initially planned. This caused some
confusion in the intervention group resulting in the exclusion of 4 patients from the final
results. After consultation with the clinic nurse and the research assistant, the determination
was made that the clinic nurse would prescribe the 8 a.m. and 8 p.m. schedule to coincide
with the SMS reminder.

Adherence
Only two participants did not complete the regimen resulting in exclusion from the
study. Pill counts revealed only one dose left in the returned bottles, which was from a
patient’s case that was redefined as complicated and excluded. All other pill counts were 0
(zero) as required for the category probably adherent.
No significant association was found between SMS reminders and
pharmacoadherence among malaria patients being treated with ACT when evaluated with
respect to those who received the SMS reminders and those who did not (χ2=0.19, df=1,
p=0.67). Findings indicated that 64.6% (n=31) of those in the intervention group were
probably adherent compared with 68.8% (n=33) of those in the control group (see Table 6).
Of the total, 66.7% (n=64) were classified as probably adherent and 33.3% (n=32) as
probably non-adherent. Of those identified as probably adherent, 51.5% (n=33) were male
and 48.5% (n=31) were female.
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Table 6: Adherence Results

Probably Adherent

Intervention (SMS)
# (% of group)
31 (64.6%)

Control (No SMS)
# (%)
33 (68.8%)

Total
# (%)
64 (66.7%)

17 (35.4%)

15 (31.2%)

32 (33.3%)

48

48

96

Probably
non-Adherent
Total

Twenty participants had probable perfect adherence as defined by digitally-recorded
MEMS bottle openings occurring only during the timeframes of adherence and only the
required six openings with one in each timeframe. Of those, 12 (66.7%) were in the
intervention group and 8 (33.3%) in the control group indicating that the SMS intervention
may have been helpful for staying within the prescribed parameters. However, when these
data were analyzed by Pearson’s Chi-square test of association, the result was still not found
to be significant (χ2=1.01, df=1, p=0.32). Though underpowered, these data may provide
direction for further research.
Table 7: Probable Perfect Adherence Results

Probably Perfectly
Adherent
Probably Not
Perfectly Adherent
Total

Intervention (SMS)
# (% of group)
12 (25%)

Control (No SMS)
# (%)
8 (16.7%)

Total
# (%)
20 (20.8%)

36 (75%)

40 (83.3%)

76 (79.2%)

48

48

96

Binary logistic regression was used to determine if any other independent variables
(town, age, gender, belief in traditional treatment, prior treatment, fever time, education,
employment status, family income and radio) were associated with adherence. The variables
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languages read and languages written were excluded due to small sample sizes in some
groups resulting in widely varying, insignificant statistical results. To increase statistical
power and simplify interpretations the following variables were collapsed into binary
variables for the logistic regression: age, education, family income, fever time. A forward
step-wise procedure was then executed. Analysis indicated that there were no variables
associated with adherence (see Table 8) (p<0.05).
Initial binary logistic data were screened and regression results indicated that the
overall model fit was questionable (-2 Log likelihood = 115.9) and was not statistically
significant in distinguishing between groups (χ2 = 6.31; df = 10; p = 0.79). The model
correctly classified 64.6% of the cases, a decrease of 2.1% compared to the model without
the independent variables considered (66.7%). Regression coefficients are presented in Table
8. Both the Wald statistics and the odds ratios indicate little change in the likelihood of
adherence based on the SMS intervention.
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Table 8: Binary Logistic Regression of Variables
B

Wald

df

OR

95% CI

p

Town
Village
Rural

-0.55

1.0

1

1.0 (ref)
0.58

0.20, 1.7

0.31

Age
18-35 yrs
>35 yrs

-0.72

2.1

1

1.0 (ref)
0.49

0.19, 1.30

0.14

0.26, 2.2

0.61

Gender
Male
Female

-0.28

0.27

1

1.0 (ref)
0.76

Traditional
belief
Yes
No

0.63

0.26

1

1.0 (ref)
1.9

0.17, 21.2

0.61

0.16, 3.6

0.73

Prior tx
Yes
No

-0.28

0.12

1

1.0 (ref)
0.76

Reported
fever time
<24 hrs
>24 hrs

-0.33

0.47

1

1.0 (ref)
0.72

0.28, 1.9

0.49

Education
Gr 1-9
> Gr 9

-0.65

1.6

1

1.0 (ref)
0.52

0.19, 1.4

0.20

0.20, 3.2

0.77

Employed
Yes
No

-0.21

0.087

1

1.0 (ref)
0.81

Family
income
0-500 Kr
>500 Kr

-0.38

0.21

1

1.0 (ref)
0.68

0.13, 3.5

0.64

1

1.0 (ref)
0.56

0.19, 1.7

0.30

Own radio
Yes
No

-0.59

1.10
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However when binary logistic regression was run using the same variables against
probable perfect adherence, three factors were significant: Lower age (OR 0.099, 95% CI
[0.024, 0.41], p<0.01), owning a radio (OR 0.096, [0.019, 0.47], p<0.01), and residing in a
village rather than rural (OR 0.116, [0.026, 0.51], p<0.01).
In addition, the Omnibus Test of Model Coefficients resulted in χ 2=27.04 (df=1,
p<0.01). Results indicated that the overall model fit using probable perfect adherence was
better than the fit using probable adherence (-2 Log likelihood = 71.2). The model correctly
classified 85.4% of the cases, an increase of 6.2% compared to the model without the
independent variables considered (79.2%).
In addition, the mean number of bottle openings for the sample (N=96) was 7.8 for a
regimen that only required six openings. The number of openings ranged from 5 to 15 with
the majority of the participants opening the bottle more than the necessary 6 times.

End of Study Questionnaire
The results of 24 self-report end-of-study questionnaires (see Table 9 & Appendix J)
provide data for possible further research. Responses to the question regarding awareness of
a second group indicated that there was no awareness so contamination is not suspected.
When asked what aspect of the regimen was most helpful for taking the medication, results
were mixed, but 20 of the 24 (83.3%) included SMS as being one of the most helpful
components.
Regarding the helpfulness of the timing of the SMS the 25% who indicated that the
evening reminders seemed most helpful suggested that it was because of the many
distractions that they faced during that time of day. One participant mentioned that both were
helpful “because they were encouraging me showing that they care for my health.”
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The final question was to gauge whether participants viewed ACT as a primary or a
secondary approach to treatment. When asked if they sought help prior to coming to the
clinic, only two respondents replied that they had tried alternative treatment. Results
indicated that seeking medical treatment from a professional healthcare provider seems to be
the primary choice of most of those (92%) presenting to the clinic. Further qualitative studies
are necessary to determine true predictors of and factors affecting adherence.
Table 9: End of Study Questionnaire Results
Question

Responses
# (%)

What was most helpful in taking the medication?
Pill bottle

0 (0%)

SMS reminder

8 (33.3%)

Packaging (blister pack)

2 (8.3%)

SMS & packaging

2 (8.3%)

SMS & pill bottle

2 (8.3%)

Pill bottle & packaging

2 (8.3%)

Combination of SMS, pill bottle & packaging

8 (33.3%)

Which SMS messages were most helpful for reminders?
Morning reminder

3 (12.5%)

Evening reminder

6 (25.0%)

Both equally helpful

11 (45.8%)

No response

4 (16.7%)
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CHAPTER FIVE: DISCUSSION
Literature Review and Theoretical Framework
P. falciparum malaria-associated infection continues to burden individuals and public
health services in sub-Saharan Africa in the areas of health, longevity and economics.
Despite having the best medication available to treat an illness, pharmacoadherence remains
an integral key to effective treatment.
While the association between the SMS and adherence were not significant, the rates
of adherence for both control (68.8%) and intervention groups (64.6%) were higher than
other comparable measures of ACT adherence in sub-Saharan Africa. Best practice methods,
such as the pictorial instruction, were intentionally implemented in this study to maximize
adherence rates and may have contributed to the higher level of adherence. The Hawthorne
effect may also have led to the higher rates. When the definition of adherence included
consideration of the medication timing in the literature, probable adherence ranged from
38.7% (Lemma et al., 2011) to 48.3% (Gerstl et al., 2010). It was only when factors such as
timing were removed that rates of ACT adherence in other studies fell in a similar range to
the current study (Cohen et al., 2012; Lawford et al., 2011). The higher rate of adherence
may be attributed to the use of the MEMS bottle, which has been found to improve adherence
(Fallab-Stubi et al., 1998; Kahook, 2007). The additional attention given to the patients in
the research might also contribute, though no base-line adherence rates are available for
patients in the Copperbelt Province of Zambia.
Though the literature review indicated an association between SMS and adherence,
the current study’s data indicated no such association. Most studies measuring SMS direct to
patients and indicating association were conducted with ART adherence, but since ACT
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adherence is a short-term regimen, results were expected to be similar or better (Horvath et
al., 2012; Kunutsor et al., 2010; Lester et al., 2010; Pop-Eleches et al., 2011).
The reasons for lack of association between SMS and ACT adherence in the current
study may be difficult to discover. SMS may provide simply another tool in the
comprehensive, multi-pronged approach that must be tailored to local contexts (Chi &
Stringer, 2010). The current study certainly reinforces the ease of implementation and
technical feasibility suggested by others regarding the use of the mobile phone for adherence
in resource-limited settings (Crankshaw et al., 2010; Haberer & Kiwanuda, 2010; Kamanga
et al., 2010). However, the lack of research using mobile phones for malaria leaves little
material with which to compare (Kaplan, 2006; Zurovac et al., 2012).
When using the probable perfect adherence in logistic regression, several of the
factors identified in the literature review were also found to be significant in this study. The
three variables, lower age, owning radio, and living in a village were associated with
increased rates of probable perfect adherence across all study participants. The lower age
may be associated due to the young being more open to treatment by medication since they
did not live through much of the traditional treatment history that preceded modernity.
Owning a radio may indicate a higher socio-economic status and/or being exposed to mass
media anti-malarial campaigns. Village life would bring more exposure to the experience of
others who have benefited from medical treatment compared to those living in rural areas.
The likelihood of electricity in the village also brings an added level of technology, and with
it, education.
The use of the TPB, while helpful, proved problematic to measure as a cognitive
model. It is difficult to determine if the SMS intervention was successful in improving
intention to adhere, one aspect of perceived behavioral control in the TPB. Intention to
adhere was assumed in this study, and the measurement of this research targeted adherence
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behavior rather than intention. Several individuals responded to the SMS with appreciative
SMS return responses for the attention and care offered. One responded, “Thanks for your
encouragment, i even went for work. May God bless you gudnite [sic].” Another, “yes im
[sic] feeling better now thank you.” And another, “Thank you very much. I have taken it im
[sic] better now.” Anecdotally, many patients responded positively to the SMS reminders as
the literature suggests (Dean et al., 2012; DeRenzi et al., 2012; Donald et al., 2007; Hoffman
et al., 2009; Jones et al., 2012).
The potential barriers identified in the application of the TPB to pharmacoadherence
that prevent the planned behavior (i.e. taking prescribed medication according to regimen)
from becoming actual behavior were forgetfulness, bad taste, negative side effects and
subsiding symptoms. Though the use of the SMS reminder intervention addressed primarily
the forgetfulness aspect, it did not address and overcome any barriers to actual control that
resulted in improved pharmacoadherence behavior. The reasons for that failure are not
readily apparent although multiple challenges existed that may have contributed to the poor
association.

Evaluation of Design
Introduction
Every study is only as good as the integrity of its design. One must consider multiple
factors that affect both internal and external validity and how they might have influenced the
study.

Internal Validity
Multiple factors threatened the internal validity, and the design incorporated measures
to address some of these threats. Randomization, homogeneity and standardization helped to
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create a balanced design. One of the primary threats in any experiment is that factors other
than the intervention may contribute to the measured difference, and therefore must be
considered. Randomization was used to assign participants into either the intervention or
control group, and both groups contained an equal number of subjects from the same village.
Demographic logistical analysis was performed to ensure homogeneity, which was verified
through the Chi-square test of homogeneity. Thorough training of the assistant and scripting
of the educational material standardized the interaction with both the intervention and the
control group. The script was also worded in such a way as to attempt to eliminate
experimenter bias or undue influence by being reviewed by a local consultant prior to
implementation. To avoid the possibility of being perceived as coercive, the PI provided
vigilant monitoring through a systematic review of random audio recordings of the assistant’s
interactions with participants that better assured adherence to standardization. The PI found
no significant variations from the script. Applying the measures described mitigated the
identified threats to internal validity.
In addition, valid statistical analysis requires an adequate sample size. The target
sample size (N=88) in this study was determined with G*Power software and was exceeded
with a sample size of 96. There are no identified significant threats to internal validity in this
study.

External Validity
Additional measures were critical to ensure external validity allowing generalizability
to the population of interest. A representative sample design was one necessary measure
implemented to enhance external validity. While the convenience sample used in this design
was a nonprobability sample, the prevalence of malaria occurrence and the homogeneity of
the village help enhance generalizability.
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The Hawthorne effect, novelty effects and experimenter effects may limit
generalizability (Polit & Beck, 2004). The Hawthorne effect describes the behavior that may
result because the participants know that they are in a study, and therefore behave differently
than if they are not. This effect was impossible to avoid given the use of the MEMS bottle
and the notification requirements of the IRB. Expectancy effects may be motivated by a
desire to please the assistant, by being adherent, or by some incentive perceived or actual.
According to the clinic staff, the study participants displayed a much higher rate of return to
the clinic post-treatment than non-participants thus enabling follow-up and further health
assessment. The phone card incentive that was offered to all participants in both groups for
returning the MEMS caps and bottle provides a probable explanation for the increased rate of
return.
The novelty effect refers to the effect that the relatively new technology of SMS
and/or the electronic pillbox, might have on patient adherence incentive. Though novelty
effects can limit external validity, they are extremely difficult to address and to quantify.
However, the advantage of the version of the MEMS cap used in this study is that it is not
overtly technological. The appearance is similar to a standardized pill bottle somewhat
limiting the novelty effect.
Experimenter effects operating in the assistant and the PI may also introduce some
bias. The intellectual and/or emotional investment of desiring an intervention to be
successful could lead to misinterpretation or subconscious guiding of the patients. The PI as
a white Westerner in an African culture avoided direct contact with the Zambian clients in
order to minimize experimenter effects. Careful training of the assistant, script writing,
recording, and systematic monitoring of compliance to the script also helped to minimize
these concerns.
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Methodological Assumptions and Limitations
Methodological assumptions and limitations in this study fall into the categories of
design, sampling, measurement, statistical analysis and other challenges.

Design
One study limitation was the possibility of contamination. While participants were
masked to the intervention, both experimental and control groups reside in the same highly
social community; therefore, information regarding the group differences was investigated to
determine significance. Since none of those responding to the end-of-study questionnaire
indicated knowledge of the other group, contamination was considered negligible.
A further limitation of the study was that receipt and timing of SMS messages were
not confirmed due to the lack of availability of read receipts for SMS in Zambia. The
participants’ phones were not reviewed to determine if and when the messages that were sent
were, in fact, received and read. Of course, even if read, there is no means of determining
whether the intended participant read them, a reasonable concern recognizing the shared
nature of cell phones in low-resource settings.
Other issues that could negatively impact the timeliness of the receipt of the SMS
include participants leaving the coverage area, not being in the vicinity of their phone, or
having depleted mobile phone batteries without immediate access to electricity to recharge
them.

Sampling
Using a convenience sample as opposed to a probability sample can result in selection
bias (Oleckno, 2002). Due to the sampling being taken from a single village location, patient
demographic characteristics may differ from those in other regions of the country. Those
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who participated and/or those who qualified to participate may possibly have differed
demographically from those who did not. Those who did not qualify were not asked to
complete a demographic questionnaire largely due to linguistic and literacy challenges.
Future studies could implement this process in order to better explore generalizability. While
all visible observations indicate that Fisenge is a typical rural Zambian village in the
Copperbelt Province, clinic and village statistics were not available to justify this assumption,
limiting generalizability without further statistical substantiation.

Measurement
The study presents several measurement challenges. The largest challenge to
accuracy and precision comes with defining and measuring actual adherence. If a patient
consumes the medication within one hour of the prescribed time, is he/she adherent? Are
participants adherent if within two or three hours? Precision in measuring adherence proves
problematic without clearly defined adherence parameters. The measurement parameters
chosen herein are based on an exploration of adherence definitions in malaria research
literature and a strict definition was selected for conservative purposes (Lefevre et al., 2001;
WHO, 2012).
DOT best assures actual adherence to a prescribed regimen, but multi-day regimens
with outpatients render such assurance difficult at best. Electronic monitoring such as the
MEMS cap helps, but it records only the opening and closing of the pill bottle, not ingestion
of medication. The participants may also save or give away the medication resulting in a
false indication of adherence. The best assurance and most precise description of adherence
that a researcher is able to achieve given these limits is probable adherence.
In this research, the assumption was that if a MEMS cap recorded an opening during
the adherence time window probable adherence was assumed, even if the bottle was opened
75

at other times between adherence windows. The excessive number of bottle openings may be
due to the novelty of a new dispenser since most medication from the clinic is dispensed in
small, clear, plastic medication bags with zip seals. Both groups were using the same type of
electronic pillbox and the same standard of adherence, so the precision of the measurement of
actual adherence was less critical in this study than the consistency of measurement between
groups in order to ensure comparability and to validate the use of the Chi-square statistic.
The small number of those identified as probably perfectly adherent verifies the difficulty in
determining adherence even with the MEMS cap.
Another factor limiting the measurement of adherence in this study is the
dichotomous nature of adherence chosen in this design when assigning participants to either
probably adherent or probably non-adherent. There is no measurement of partial adherence
or analysis of different aspects of adherence like the specifics of timing or number of pills
taken other than an end of study pill count. Consistency in the definition and measurement of
adherence is critical as related studies are conducted.

Statistical Analysis
One assumption of the Chi-square test is that no cells have a count of five or less.
Our analysis and sample size met that assumption, validating the use of Chi-square.

Other Challenges
Every study faces challenges, but those conducted in low-resource settings, such as
much of sub-Saharan Africa, face a unique set of challenges, each one an opportunity for
further exploration. Factors that influence pharmacoadherence in Zambia likely have a wide
application to other sub-Saharan settings.
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One of the challenges in this study was the communication barrier between the PI and
others involved in the research – the assistant, the clinic nurse and the patients. Though the
assistant was fluent in English, miscommunication still occurred. The explanation of
randomization, for example, took significant explaining multiple times before the assistant
understood the process. This communication barrier even with those fluent in English could
potentially impact the study. Recording the assistant’s interaction with participants served to
mitigate that issue.
Another significant communication challenge is the large number of languages
spoken by the clinic’s patients. There may be communication and information biases due to
interpretation and translation issues, although such bias is most likely insignificant.
Cultural differences also proved to be challenging. Generally members of the
community have a clear understanding of the signs and symptoms of malaria and when to
seek treatment. However, beyond the signs and symptoms, there continues to be many
misconceptions on the etiology of malaria. For example, a significant number of community
members reported that malaria can be contracted by eating an unripe mango, or even from
being caught out in the rain. Curses and spells are believed to be one of the primary causes
of illness in the Copperbelt. Based on these misunderstandings, it seems that better
education and knowledge may improve not only adherence, but also prevention of the
disease. Though a greater percentage of those over grade nine (72.2%) were probably
adherent than those under grade nine (62.2%), the difference was not significant (χ2=1.03,
df=1, p=0.31). An understanding of the importance of adherence to a treatment regimen and
its link to the high rate of morbidity and mortality brought on by malaria is crucial to
motivate adherence.
Traditional African belief often attributes the causes of diseases to ancestors or
witchcraft. Two cases of superstition nearly caused the loss of data and MEMS caps. In one
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case, a patient related that her spouse encouraged her to throw the bottle down the outhouse
because it must be witchcraft that is involved: “Why else would they want to know how
many times you opened the bottle?” A second story indicated that the PI’s name (Elinda)
was so closely related to the local river goddesses (Linda, Belinda, Brenda) that there must be
witchcraft involved. Fortunately in both cases, participants discussed the matter with the
research assistant or clinic staff and returned their bottles. In retrospect, the research
intervention may have been more successful in an urban setting where education levels are
higher, belief in western medicine is widespread, and English speaking is more prevalent.
However, such a setting would also further limit generalizability to rural Zambians.
Another concern is the status of the eight who did not return their MEMS caps. It is
possible that they were aware of their failure to adhere so retained the caps to prevent
measurement. However, since four were from the control group and four from the
intervention group, any effect that would present would likely be distributed evenly between
the groups.
Some challenges involve the use of mobile phones. The cost of mobile phones and
the poverty in sub-Saharan Africa often lead to fixed shared-access mobile phones (Kalba.
2008). These mobile phones are shared among a fixed household or family, which
complicates direct and timely communication to individuals. Though the participant may still
have access as required for this study, the phone may be in use by another member of the
household at the time the SMS is sent. Future studies should consider methods of confirming
receipt of SMS reminders by the participant.
In a country where various aspects of the mobile phone industry, such as network
coverage, contribute to the use of multiple subscriber identification module (SIM) cards from
multiple providers used by each individual, one challenge is knowing to which phone number
the SMS is to be sent. Although the assistant only asked for one phone number to which to
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send the SMS, the PI would sometimes receive a response from the same participant using a
different phone number than the one given. This confusion may have led to missed messages
if a different SIM card was installed in the shared-access phone at the time of the SMS.
Alternative card use could be due to one SIM card being out of prepaid talk time or cheaper
call rates within a specific network resulting in a different SIM card being installed.
Another challenge was the need to reuse MEMS caps for multiple patients, a practice
that is discouraged by the manufacturer, Aardex (2013). The primary reason for the
discouragement of this practice is the possibility of cross-contamination, however since
malaria in a non-contagious disease, and because the pills were in blister packs within the
bottles, this objection was not considered substantive. While the multiple use of each bottle
did not impede the research, the compilation of the data was slightly more complicated by the
reuse of the MEMS caps.
The only economic challenge associated with long-term use of this SMS intervention
with the MEMS caps is the expense, which at this time is cost-prohibitive in resource-limited
settings. A comprehensive cost analysis would need to be done for any large-scale
applications of SMS reminders for adherence. Such costs may include investments in
computer equipment and salaries for administrative purposes. However, the costs of all other
aspects of the study, including the SMS (approximately USD $0.01/message or a total of less
than $10 for all messages in the current study) and the ACT treatment proved negligible due
in part to government supply of free ACT to all public clinics, indicating that the intervention
is both actionable and practical for future research where similar conditions exist.
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Implications for Nursing Practice and Policy
Practice
The study indicates few implications to nursing practice due to the lack of association
between SMS and adherence other than to add to the current body of knowledge. However,
there are some implications for nursing research. Pharmacoadherence is a multi-faceted
concept that will not be easily solved with any individual intervention. The SMS reminder, if
found to be associated with adherence in further research, can be used to supplement other
adherence strategies in the hope to improve pharmacoadherence not only for ACT and
malaria, but also for other long-term illnesses, where forgetfulness may be more prevalent.
The many challenges that the PI faced with communicating clearly to those of another
language and culture reinforced the necessity of adequate training and understanding for
those involved in research. One is dealing with multiple layers of tradition and traditional
understanding, which are not going to be replaced with a scientific understanding in a brief
time of training. The more one learns about the culture prior to research, the less likely
miscommunication and misunderstanding is to occur. Ideally the researcher would come
from the same culture and speak the same language as those among whom the research is
conducted. This would minimize undue influence and misunderstanding or
miscommunication. However, the assistant used in the current study was the contact person
by participants and shared both the same culture and the same language with them.
The PI used best practice standards in the current study such as blister packs and both
written and pictorial instructions. The phone card incentive may also have motivated
pharmacoadherence. The lack of adherence differences discovered and the higher level of
adherence may be due to a combination of these best practices and the incentive provided.
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Sixty-two of the participants (65%) claimed that their fever began more than 24 hours
prior to clinic arrival, however these were all self-report without thermometer verification.
Though only two participants’ malaria became complicated, health education must address
the need for earlier intervention for treatment initiation or clinic consultation in order to
reduce the risk of severe malaria infection and mortality.
Sub-Saharan Africa is in the early-majority stage of the technology adoption curve as
determined by Kalba (2008) and defined by Rogers (2003). As mobile phones become more
prevalent and the coverage and use more sophisticated, these powerful tools will be able to be
utilized in multiple ways to assist healthcare.

Policy
Global policy provides the needed framework to deliver effective healthcare services.
The United Nations has established eight Millennial Development Goals, the sixth of which
is to combat HIV/AIDS, malaria and other diseases. The third part of this target goal is to
halt and reverse the incidence of malaria by 2015 (UNF, 2012). A significant global
initiative, the RBM Partnership, was launched in 1998 bringing together the WHO, the
United Nations Children’s Fund (UNICEF), the United Nations Development Programme
(UNDP) and the World Bank in an effort to provide an effective and coordinated global
response to malaria. Today RBM embraces over 500 partners including malaria endemic
countries (RBM, 2010).
The National Malaria Control Programme of Zambia falls under the Directorate of
Public Health and Research in the Ministry of Health and has established the Zambian
National Health Strategic Plan 2011-2015 (MOH, 2011). One of the main objectives of this
plan is to reduce the annual incidence of malaria to 75 per 1,000 by 2015 exceeding the RBM
goal (RBM, 2010). Two strategies in the plan, a focus on health service delivery by
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promoting support for health management, and targeting malaria treatment interventions offer
opportunities for technology to be used to improve pharmacoadherence (MOH, 2011).
However, any such use is affected by mobile network coverage and marginalized areas must
be targeted by national policies to ensure the effectiveness of such interventions.
The local policy strategy involves management of malaria in health facilities,
communities and homes using ACT as a first-line drug to increase access to prompt malaria
treatment. A challenge to achieving this action point is that, at the provincial and district
levels, there are limited human resources to coordinate treatment strategies, increasing the
necessity for discovering methods by which to maximize effectiveness (RBM, 2010).
Researchers are compelled to continue to explore technological interventions such as SMS to
assist in this effort.

Recommendations for Further Research
The additional data collected from the end-of-study questionnaire provides
groundwork for further research related to pharmacoadherence. In particular, the data
provides a foundation for a follow-up qualitative study on the factors that may influence
pharmacoadherence, as well as a study of the contextual traditional assumptions that impede
adherence. If some factors could be identified as being associated with non-adherence,
research could target those related causes more effectively.
While SMS reminders were not significantly associated with increased
pharmacoadherence, addressing some of the other barriers may help overcome the human
limitations of poor adherence. Further research could investigate means of addressing these
barriers through the use of mobile phones. For example, using a voice call rather than SMS
to contact the patient would allow dialogue, possibly enlightening the caregiver to other
unidentified barriers. Use of voice reminders as opposed to SMS could be explored to
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determine if the social aspect of verbal communication enhances adherence. However, such
interventions also increase the time and financial costs involved.
Though the length of SMS has been addressed in some studies (Horvath et al., 2012)
the content of the SMS messages is also an aspect that could benefit from further research.
Perhaps the wording of the message could be improved or other elements added or the
message sent in the local language. Another possibility could explore an SMS response back
from the participant with information on the time the medication was taken. However,
returned communication increases the cost to the patients as mobile phone charges are
applied to the contacting party in Zambia.
A standardized 8 a.m. and 8 p.m. protocol of SMS messages was used for this study,
however the exact timing of the SMS could be further tailored to the participant’s schedule.
When a participant is diagnosed with malaria and offered the ACT, they could be asked what
time in the morning and evening would be best for them to take the medication and schedule
the SMS reminders accordingly. Since the twelve-hour difference is somewhat flexible, they
could , for example, take their morning dose at 7 a.m. and their evening dose at 8 p.m. If
automated software were used to initiate the SMS reminders, the additional work to
customize the timing of the SMS messages to the lifestyle of the patient would be negligible.
One of the areas ripe for research in sub-Saharan Africa is the dependability of selfreport which is the primary method of measurement in many ACT pharmacoadherence
studies (Cohen et al., 2012; Lemma et al., 2011; Onyango et al., 2012). In a culture where
the intention is to please and time schedules are not a priority, this method has little reliability
(Lewis, 2006). One study in Malawi comparing self-report to MEMS and pill count resulted
in only 0.8% (n=3) admitting to missing doses on self-report. However 9.4% (n=17) had
remaining doses in their MEMS bottles when returned (Bell et al., 2009). In addition,
research measuring adherence indicated that MEMS results called into question the 100%
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adherence made by SMS self-report (Haberer & Kiwanuda, 2010). Further research is
needed possibly using MEMS or virtual DOT to measure the reliability and validity of selfreport and to determine ways to more accurately measure actual pharmacoadherence.
MEMS caps offer a more reliable method of measuring/encouraging
pharmacoadherence than self-report, however the cost of the caps renders them impractical
for widespread use in sub-Saharan Africa and other low-resource settings.
While this study did not determine the satisfaction of the patients with the
effectiveness of ACT treatment, further research could explore this area to determine if it is
associated with a higher level of adherence.
The MEMS data indicated that in several cases there were substantially more bottle
openings than there were doses. Further study could seek to determine the reasons for the
multiple openings especially given that part of the briefing by the assistant included a request
not to open the bottle except when taking medication. Determining the reason for the extra
openings may help identify methods to limit these and thus more accurately measure
pharmacoadherence.
Two life-long residents of Africa, one an American, born and raised in central Africa
and the other an indigenous leader in the community describe the nature of paradigm shifts
and obstacles to behavioral change in this context. Because the culture of central Africa is
very resistant to change, Rogers’ (2003) Diffusions of Innovations model warrants further
exploration as a theoretical backdrop to research implementing new methodologies or
modern technological tools. Life in this culture has traditionally been fraught with danger
from famine, war, disease and forced migration. Those who were quick to embrace change
often died because they gave up their traditional forms of protection and were no longer able
to deal with the recurring African dangers. Thinking in terms of inertia and momentum one
might say that this culture exhibits a great deal of inertia where change is concerned and
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health practices are no exception. Clinics and hospitals see many patients in urban areas, but
a large and mostly unidentified segment of the population continues to rely on traditional
healing through charms, plants or combinations of both. Many rural communities in Zambia
have no access to western medicine so traditional cures are all that is available. Gradually the
tide has changed in urban areas and many people now come to clinics for treatment.
Momentum seems to be starting to build in favor of western medicine as people experience
and witness the effects. The western medicinal approach to the treatment of malaria can be
considered a whole new approach to medicine in sub-Saharan Africa and would naturally
experience all the normal resistance that the culture exhibits towards innovation. As the
incorporation of this method into the normal treatment of malaria continues, the inertia might
gradually be overcome and with it momentum might begin to move the culture towards
accepting this new medical practice. Once accepted, it would become the new status quo and
adherence would be strongly motivated by the same cultural resistance to change that initially
made it difficult (J. J. Enright & R. S. Kilembo, personal communication, April 5, 2014).
Another method suggested by the Diffusion of Innovations model to speed up the
acceptance of this healthcare model would be to actively recruit the traditional leaders and
healers in the community to endorse and advocate this approach (Rogers, 2003). Traditional
chiefs’ power and authority is limited in urban areas in Zambia, but both are significant in
rural areas. A sustained endorsement by the chief and sub-chiefs might have a profound
effect on the acceptance of this method. Likewise, bringing the traditional healers in a
community on board through dialogue and education would initiate a significant endorsement
of the method. Zambia is overwhelming Christian and bringing local pastors, ministers and
priests on board would provide another way in which traditional figures of authority would
lend their influence to bring about acceptance of this method (J. J. Enright & R. S. Kilembo,
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personal communication, April 5, 2014). Clearly, context and culture need to be seriously
considered in any study design conducted by westerners in sub-Saharan Africa.

Summary and Conclusion
All study results from this research will be shared with the external collaborator, the
Tropical Disease Research Centre, Ndola, Zambia, and with the Zambian Ministry of Health,
and submitted for possible publication. The aggregate results will also be made available to
the participants at their request.
Preventing malaria is the best strategy for reducing morbidity and mortality.
However, once infected the value of ACT pharmacoadherence for treatment justifies
continued attempts to improve the statistics in order to combat malaria in sub-Saharan Africa.
Though the results of the current study did not find a significant association between SMS
and pharmacoadherence, it was the first of its kind using patient-centered communication for
ACT adherence in sub-Saharan Africa and was fraught with challenges. The possibilities for
further improvement in pharmacoadherence using technology and mobile phones specifically
merit further exploration, and offer great opportunity to help bring an end to this deadly
disease. Today, 108 countries in the world are free of malaria (Feacham & Malaria
Elimination Group, 2009). The hope is to make it 109.
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APPENDIX A: SMS MESSAGE SEQUENCE
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Day 1, dose 1: Given at the clinic – no SMS.



Day 1, dose 2: “Good afternoon (or evening, if appropriate)! It’s time to take your
malaria pills.”



Day 2, dose 1: “Good morning! It’s time to take your malaria medicine.”



Day 2, dose 2: “Good evening! It’s time to take your malaria pills.”



Day 3, dose 1: “Good morning! It’s time to take your malaria medicine. I hope you
feel better!”



Day 3, dose 2: “Good evening! It’s time for your last malaria pills.”

88

APPENDIX B: INVITATION TO PARTICIPATE
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APPENDIX C: DEMOGRAPHIC QUESTIONNAIRE
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Demographic Questionnaire
Patient’s ID#:

1. Interviewer name:
2. Patient’s name:
3. Town of residence:
4. Contact information:
5. Age:
6. Gender: (Circle one) Male

Female

7. Do you believe that malaria can be treated without medication?
(Circle one) Yes

No

8. Have you taken malaria medication before?

(Circle one) Yes

No

9. Do you have continuous access to a mobile phone throughout the next 3 days?
(Circle one) Yes

No

If yes, what is the number?
10. When did your fever begin? (If >1 day ago, patient cannot participate)
(Circle one)

0-12 hours

within 12-24 hours

> 24 hours

11. What is the highest grade in school that you have completed?
(Circle one) 1 2 3 4 5 6 7 8 9 10 11 12 College
12. What languages do you read and write? (Check all that apply)
READ:___English

___Bemba

___Other: _______________________

WRITE:___English

___Bemba

___Other: _______________________

13. Are you currently employed? (Circle one) Yes

No

14. What is your total family monthly income in Kwacha?
0-100K

100-500K

500-1000K

15. Do you own a radio? (Circle one) Yes
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>1000K
No

APPENDIX D: DATA COLLECTION TOOL
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Medication Event Monitoring System (MEMS): AARDEX Group Ltd, 1950 Sion/
Switzerland; www.aardexgroup.com
MEMS cap version 6

MEMS cap unique reference number
MEMS Communicator/Reader plugged into Windows-based computer with MEMS
cap in reading position
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University of Central Florida Institutional Review Board
Office of Research & Commercialization
12201 Research Parkway, Suite 501
Orlando, Florida 32826-3246
Telephone: 407-823-2901 or 407-882-2276
www.research.ucf.edu/compliance/irb.html

Approval of Human Research
From:

UCF Institutional Review Board #1
FWA00000351, IRB00001138

To:

Elinda E. Steury and Co-PIs if applicable:

Date:

February 12, 2014

Dear Researcher:
On 2/10/2014, the IRB approved the following human participant research until 02/09/2015 inclusive:
Type of Review:
Project Title:
Investigator:
IRB Number:
Funding Agency:
Grant Title:
Research ID:

UCF Initial Review Submission Form
Short Message Service (SMS) reminder intervention for malaria
medication adherence in Zambia.
Elinda E. Steury
SBE-13-09805

N/A

The scientific merit of the research was considered during the IRB review. The Continuing Review
Application must be submitted 30days prior to the expiration date for studies that were previously
expedited, and 60 days prior to the expiration date for research that was previously reviewed at a convened
meeting. Do not make changes to the study (i.e., protocol, methodology, consent form, personnel, site,
etc.) before obtaining IRB approval. A Modification Form cannot be used to extend the approval period of
a study. All forms may be completed and submitted online at https://iris.research.ucf.edu .
If continuing review approval is not granted before the expiration date of 02/09/2015,
approval of this research expires on that date. When you have completed your research, please submit a
Study Closure request in iRIS so that IRB records will be accurate.
Use of the approved, stamped consent document(s) is required. The new form supersedes all previous
versions, which are now invalid for further use. Only approved investigators (or other approved key study
personnel) may solicit consent for research participation. Participants or their representatives must receive
a copy of the consent form(s).
In the conduct of this research, you are responsible to follow the requirements of the Investigator Manual.
On behalf of Sophia Dziegielewski, Ph.D., L.C.S.W., UCF IRB Chair, this letter is signed by:
Signature applied by Joanne Muratori on 02/12/2014 02:43:27 PM EST

IRB Coordinator
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TROPICAL DISEASES

RESEARCH CENTRE

Tel/fax 260 21 1 613303/602737
Email: MulengaM@tdrc.org.zm
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NDOLA, ZAMBIA
OFFICE OF DIRECTOR

Our Ref: TRC/D/PP/04/13
11th April 2013
Elinda Enright Steury
Associate Professor
Brevard Community College
Institute of Nursing, 250 Community College Parkway
Building 1, Room 327B
MELBOURNE, FL 32909
United States of America
Dear Madam
RE:

LETTER OF SUPPORT

Project Title:

Research Study Exploring the Use of the Mobile Phone through
Short Message Service (SMS) to Improve Adherence to Malarial
Medication Therapy

We thank you for your letter which we received on 9th April 2013 in which you
requested our institution to be an external collaborator to support your research
study.
As a research institution mandated to conduct research in this country, we are
happy to act as external collaborator with you through the College of Nursing at the
University of Central Florida on this project.
We are willing to give advice on all pertinent regulations and policies including Ethics
Review Committee approval and any requirements that may relate to this study.
We look forward to collaborating with you.
Yours faithfully
TROPICAL DISEASES RESEARCH CENTRE

Dr Modest Mulenga - MD, DTM&H, MSc, PhD
DIRECTOR
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APPENDIX J: END OF STUDY QUESTIONNAIRE
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1. Were you aware that there was another group in the study whose conditions were
different than yours?
2. What was most helpful for you in taking the medication – the pillbox, the SMS, the
packaging, a combination or other?
3. Which SMS messages that you received were most helpful?
4. Did you seek help for your illness from anyone before you came to the clinic and if
so, who?
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